[5์ฃผ์ฐจ]

[6์ฃผ์ฐจ]

[7์ฃผ์ฐจ]

์ƒ๋ถ€ ์†Œํ™”๊ธฐ์˜ ๋Œ€ํ‘œ ์ฆ์ƒ์€ ๊ตฌํ† , ํ•˜๋ถ€ ์†Œํ™”๊ธฐ์˜ ๋Œ€ํ‘œ ์ฆ์ƒ์€ ์„ค์‚ฌ.

Fecal score Chart (1-7)

์„ค์‚ฌ๋ฅผ ํฌํ•จํ•œ ๋ณ€์˜ ์–‘์ƒ์„ ๊ฐ๊ด€ํ™”๋œ ์ˆ˜์น˜๋กœ ๊ธฐ๋ก๋  ์ˆ˜ ์žˆ๋„๋ก ์ˆ™์ง€.

๋ฌธ์ œ๊ฐ€ ๋˜๋Š” ์žฅ์˜ ์œ„์น˜๊ฐ€ ์†Œ์žฅ์ธ์ง€, ๋Œ€์žฅ์ธ์ง€ ๋Œ€๋žต์ ์œผ๋กœ ์œ ์ถ”ํ•  ์ˆ˜ ์žˆ์Œ. ์„ค์‚ฌ๊ฐ€ ์žˆ์œผ๋‚˜ ์ ์  ๋‚˜์•„์ง€๋Š” ์„ค์‚ฌ์ธ์ง€, ์•„์ฃผ ์‹ฌํ•œ ์„ค์‚ฌ์ธ์ง€ ๊ฐ๊ด€์ ์œผ๋กœ ํ‰๊ฐ€ํ•˜๊ณ  ๊ธฐ๋กํ•  ์ˆ˜ ์žˆ์Œ.

  • 1~3๊นŒ์ง€๊ฐ€ ์ •์ƒ๋ณ€์˜ ๋ฒ”์ฃผ.
  • 4๋ถ€ํ„ฐ๋Š” ์„ค์‚ฌ.
  • 4-5๋‹จ๊ณ„ : ๋Œ€์žฅ์„ฑ ์„ค์‚ฌ. ํ˜•ํƒœ๋ฅผ ๊ฐ€์ง€๊ณ  ์žˆ๊ณ , ์•„์ฃผ ์‹ฌํ•˜์ง€ ์•Š์Œ.
    • ์†Œ์žฅ์—์„œ ์ˆ˜๋ถ„๊ณผ ์˜์–‘๋ถ„์ด ๋งŽ์ด ํก์ˆ˜๋œ ๋’ค, ๋Œ€์žฅ์—์„œ ์ถ”๊ฐ€์ ์œผ๋กœ ์ˆ˜๋ถ„์„ ํก์ˆ˜ํ•˜๊ณ  ์œคํ™œ ์—ญํ• ์„ ํ•จ.
    • ๋”ฐ๋ผ์„œ ๋Œ€์žฅ์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธฐ๋ฉด ์•„์ฃผ ์‹ฌํ•œ ํ˜•ํƒœ๋Š” ์•„๋‹˜.
  • 6-7๋‹จ๊ณ„ : ์†Œ์žฅ์„ฑ ์„ค์‚ฌ. ํ˜•ํƒœ๋ฅผ ๊ฐ€์ง€์ง€ ์•Š์Œ.
    • ์†Œ์žฅ์—์„œ ๋ฌผ์„ ๋‹ค๋Ÿ‰์œผ๋กœ ํก์ˆ˜ํ•˜๊ณ , ์†Œํ™”ํšจ์†Œ๋ฅผ ๋ถ„๋น„ํ•˜์—ฌ ์†Œํ™”ํ•จ.
    • ์†Œ์žฅ์— ๋ฌธ์ œ๊ฐ€ ์ƒ๊ธฐ๋ฉด ๋ณ€์— ํ›จ์”ฌ ๋งŽ์€ ์ˆ˜๋ถ„์ด ํฌํ•จ๋˜๊ณ , ์†Œํ™”๊ฐ€ ๋‹ค ๋˜์ง€ ์•Š์•„ ์Œ์‹๋ฌผ์ด ๋ถ€ํŒจํ•˜๋Š” ํ˜•ํƒœ๋กœ ๋‚˜ํƒ€๋‚จ.
ScoreSpecimen exampleCharacteristics
1- ๋งค์šฐ ๋‹จ๋‹จํ•˜๊ณ  ๊ฑด์กฐํ•ด์„œ ์•Œ์•Œ์ด ๋ถ„๋ฆฌ๋จ.
- ๋ฐฐ๋ณ€์„ ์œ„ํ•ด ํž˜์„ ๋งŽ์ด ๋“ค์–ด์•ผ ํ•จ.
- ์ง‘์–ด์˜ฌ๋ฆด ๋•Œ ๋ณ€์ด ๋ฐ”๋‹ฅ์— ๋ฌป์–ด๋‚˜์ง€ ์•Š์Œ.
2- ์ •์ƒ๋ณ€. ๋‹จ๋‹จํ•˜์ง€๋งŒ ๋”ฑ๋”ฑํ•˜์ง„ ์•Š์Œ. ์œ ์—ฐํ•จ(pliable)
- ๋ถ„์ ˆ๋ถ„์ ˆ์ด ๋‚˜๋‰˜์–ด ์žˆ์Œ.
- ์ง‘์–ด์˜ฌ๋ฆด ๋•Œ ๊ฑฐ์˜ ๋ฌป์–ด๋‚˜์ง€ ์•Š์Œ.
3- ์—ฐ๋ณ€. ์ •์ƒ๋ณ€๋ณด๋‹ค๋Š” ์กฐ๊ธˆ ์ˆ˜๋ถ„์ด ์žˆ์Œ.
- Log ๋ชจ์–‘(ํ†ต์งœ ๋ชจ์–‘), ํ‘œ๋ฉด์„ ์ด‰์ด‰ํ•จ.
- ๋ถ„์ ˆ์€ ๊ฑฐ์˜ ๋ณด์ด์ง€ ์•Š์Œ.
- ์ง‘์–ด์˜ฌ๋ฆด ์ˆ˜๋Š” ์žˆ์ง€๋งŒ, ๋ฐ”๋‹ฅ์— ๋ฌป์–ด๋‚จ.
4- ์ˆ˜๋ถ„์ด ๋งŽ๊ณ , soggyํ•จ(ํ๋ฌผํ๋ฌผํ•จ).
- ๋ชจ์–‘์€ ์•„์ง ์žˆ์Œ (log shaped, ํ†ต์งœ ๋ชจ์–‘)
- ์ง‘์–ด์˜ฌ๋ฆด ๋•Œ ํ˜๋Ÿฌ๋‚ด๋ฆผ (์„ค์‚ฌ์˜ ์‹œ์ž‘)
5- ๋งค์šฐ ์ˆ˜๋ถ„์ด ๋งŽ์ง€๋งŒ ๋ณ€์˜ ํ˜•ํƒœ๊ฐ€ ์žˆ์Œ.
- ํ†ต์งœ(log)๋ณด๋‹ค๋Š”, ์Œ“์•„์˜ฌ๋ ค์ง€๋Š” ํ˜•ํƒœ(piles)
- ์ง‘์–ด์˜ฌ๋ฆด ๋•Œ ๋ฐ”๋‹ฅ์— ๋ฌป์œผ๋ฉฐ, ํ˜๋Ÿฌ๋‚ด๋ฆผ.
6- ๊ฒฐ(texture)์„ ๊ฐ€์ง€๊ณ  ์žˆ์ง€๋งŒ ํ˜•ํƒœ๊ฐ€ ์—†๋Š” ์ƒํƒœ.
- ์Œ“์•„์˜ฌ๋ ค์ง€๊ฑฐ๋‚˜(pile), spot ํ˜•ํƒœ๋กœ ๋š๋š ๋–จ์–ด์ง.
7- ์ˆ˜์–‘์„ฑ ์„ค์‚ฌ. ๊ฐ€์žฅ ์‹ฌํ•œ ์„ค์‚ฌ์˜ ํ˜•ํƒœ.
- ์™„์ „ ์•ก์ƒ ํ˜•ํƒœ๋กœ ๊ฒฐ(texture)์ด ์—†๋‹ค.
- ์›…๋ฉ์ด(puddle) ํ˜•ํƒœ๋กœ ์กด์žฌ.

์†Œ์žฅ์„ฑ ์„ค์‚ฌ(Small Bowel Diarrhea)์™€ ๋Œ€์žฅ์„ฑ ์„ค์‚ฌ(Large Bowel Diarrhea)

์†Œ์žฅ์„ฑ ์„ค์‚ฌ
(Small Bowel Diarrhea)
๋Œ€์žฅ์„ฑ ์„ค์‚ฌ
(Large Bowel Diarrhea)
Volume์ด ํ›จ์”ฌ ํผ.Volume์ด ๋” ์ ์€ ํŽธ.
์ˆ˜์–‘์„ฑ(Watery) - 6, 7์ Jelly like - 4, 5์ 
์†Œํ™”๊ฐ€ ์ž˜ ๋˜์ง€ ์•Š์•˜๊ธฐ ๋•Œ๋ฌธ์—,
์ง€๋ฐฉ์ด ๋ฌป์–ด๋‚˜์˜ค๋Š” ์ง€๋ฐฉ๋ณ€(steatorrhea) - greasy, ๋ฒˆ๋“ค๋ฒˆ๋“ค
์œคํ™œ ํ˜•ํƒœ๋ฅผ ํ•˜๋Š” ์ ์•ก์ด ๋ถ„๋น„๋จ.
โ€˜๋ณ€์— ์ฝง๋ฌผ์ด ๋ฌป์–ด์žˆ๋Š” ๊ฒƒ ๊ฐ™๋‹คโ€™
์—ผ์ฆ์ด ์‹ฌํ•˜๋ฉด ์ถœํ˜ˆ์ด ๋‚  ์ˆ˜ ์žˆ์Œ.
์†Œํ™” ํšจ์†Œ์— ์˜ํ•ด ์†Œํ™”๋˜๊ธฐ ๋•Œ๋ฌธ์— ๊ฒ€์€์ƒ‰์œผ๋กœ ๋ณด์ž„.
ํ‘๋ณ€ (melena)
์†Œํ™” ํšจ์†Œ๊ฐ€ ๊ฑฐ์˜ ์—†์–ด ํ˜ˆ์•ก์ด ๊ทธ๋Œ€๋กœ ๋ณ€์œผ๋กœ ๋‚˜์˜ด.
ํ˜ˆ๋ณ€ (hematochezia)
์†Œ์žฅ ์—ผ์ฆ โ†’ ๋ฐฑํ˜ˆ๊ตฌ๊ฐ€ ์†Œํ™”๋˜์–ด ์„ธํฌ ํ˜•ํƒœ๋กœ ๋ณด์ด์ง€ ์•Š์Œ.์†Œํ™” ํšจ์†Œ๊ฐ€ ์ ์œผ๋ฏ€๋กœ WBC๊ฐ€ ๋„๋ง ์ƒํƒœ์—์„œ ์ž˜ ๊ด€์ฐฐ๋จ.
์Œ์‹๋ฌผ์ด ๋ถ€ํŒจํ•ด ๋ƒ„์ƒˆ๊ฐ€ ๋” ๋…ํ•จ.๋ณ€์˜ ๋ƒ„์ƒˆ๊ฐ€ ์žˆ์œผ๋‚˜ ์†Œ์žฅ์„ฑ๋งŒํผ ๋…ํ•˜์ง„ ์•Š์Œ.
์ด๊ธ‰ํ›„์ฆ rare์ด๊ธ‰ํ›„์ฆ(Tenesmus)
- ๋Œ€์žฅ์˜ ์—ผ์ฆ์œผ๋กœ ์ธํ•ด โ€˜์ž”๋ณ€๊ฐโ€™์„ ๋А๊ปด, ๋ณ€์„ ๋‚ด๋ณด๋‚ด๋ ค๊ณ  ํ•ญ๋ฌธ ๊ด„์•ฝ๊ทผ์ด ๊ณ„์† ๊ฒฝ๋ จํ•˜๋Š” ์ƒํƒœ. ๋Œ€์žฅ์„ฑ ์„ค์‚ฌ์˜ ํŠน์ง•.
ํ•œ๋ฒˆ์— ๋‚˜์˜ค๋Š” ์–‘์€ ๋งŽ์ง€๋งŒ,
ํšŸ์ˆ˜๋Š” 2-3๋ฒˆ/day - ์ •์ƒ ํšŸ์ˆ˜์— ๊ฐ€๊นŒ์›€.
3๋ฒˆ/day ์ด์ƒ์œผ๋กœ ํšŸ์ˆ˜ ์ฆ๊ฐ€
- ์†Œ๋Ÿ‰์”ฉ ์—ฌ๋Ÿฌ ๋ฒˆ ๋‚˜๋ˆ ์„œ ๋ณด๋ ค๊ณ  ํ•จ
๊ตฌํ†  ๊ฐ€๋Šฅ์„ฑ ๋†’์Œ
๊ตฌํ†  ์ข…์ข… ๋ฐœ์ƒ ๊ฐ€๋Šฅ
๋ถ€ํŒจ, gas๊ฐ€ ๋” ๋งŽ์ด ์ฐธ์ž˜ ๋“œ๋Ÿฌ๋‚˜์ง€ ์•Š์Œ
์˜์–‘ ํก์ˆ˜์˜ ๋ฌธ์ œ๋กœ ํ™•์—ฐํ•œ ์ฒด์ค‘ ๊ฐ์†Œ

์ฒด์ค‘ ํ‰๊ฐ€ (BCS)

  • 1-9๋‹จ๊ณ„๋กœ ๋‚˜๋‰จ.
  • 5๋‹จ๊ณ„ (์ ์ • ์ฒด์ค‘)
    • Observable waist : ์œ„์—์„œ ๋ดค์„ ๋•Œ ์ž˜๋กํ•œ ํ—ˆ๋ฆฌ ๊ด€์ฐฐ
    • Ribs felt with little fat covering : ๋งŒ์กŒ์„ ๋•Œ ๊ฐˆ๋น„๋ผˆ๊ฐ€ ์ ์ ˆํžˆ ๋งŒ์ ธ์ง
    • Min. abdominal fat : ๋ฐฐ์˜ ์ง€๋ฐฉ์ด ๋Š˜์–ด์ง€์ง€ ์•Š๊ณ  ํ—ˆ๋ฆฌ๋กœ ์—ฐ๊ฒฐ๋จ
  • 1๋‹จ๊ณ„์”ฉ ์˜ฌ๋ผ๊ฐˆ ๋•Œ๋งˆ๋‹ค ์ •์ƒ ์ฒด์ค‘ ๋Œ€๋น„ ์•ฝ 10%์”ฉ ์˜ฌ๋ผ๊ฐ„๋‹ค๊ณ  ํŒ๋‹จ.
  • ๊ฐ™์€ ํ’ˆ์ข… ์•ˆ์—์„œ๋„ ์ •ํ•ด์ง„ ์ˆ˜์น˜๋งŒ ๋ณด๋Š” ๊ฒƒ์ด ์•„๋‹ˆ๋ผ ์ฒด๊ตฌ๋ฅผ ๋ณด๊ณ  ์ •์ƒ ๋Œ€๋น„ ๋ช‡ % ๋น„๋งŒ์ธ์ง€ ํ™•์ธํ•ด์•ผ ํ•จ.
  • ๋ณดํ˜ธ์ž๋“ค์€ 6-7๋‹จ๊ณ„ ์ •๋„๋ฅผ ์ •์ƒ์œผ๋กœ ์ธ์ง€ํ•จ. ์ˆ˜์˜์‚ฌ๊ฐ€ ์ง์ ‘ ํŒ๋‹จํ•ด์•ผ ํ•จ.

ํƒˆ์ˆ˜ ํ‰๊ฐ€

% dehydrationClinical signs
< 5%- ๊ตฌํ† , ์„ค์‚ฌ์˜ ๋ณ‘๋ ฅ โ†’ ๊ธฐ๋ณธ์ ์œผ๋กœ ์•ฝ๊ฐ„์˜ ํƒˆ์ˆ˜๊ฐ€ ์žˆ๋‹ค๊ณ  ๊ฐ€์ •
5-7 %- ์ ๋ง‰์ด ๊ฑด์กฐํ•จ
- ๋“ฑ์ชฝ ํ”ผ๋ถ€๋ฅผ ๋“ค์–ด์˜ฌ๋ ธ์„ ๋•Œ ์ˆ˜๋ณต๋˜๋Š” ์‹œ๊ฐ„์ด ์ง€์—ฐ (skin elasticity loss)
โ‡’ ๊ตฌํ† ๊ฐ€ ์—†๋‹ค๋ฉด ์Œ์ˆ˜๋Ÿ‰ ์ฆ์•ก / ๊ตฌํ† ๊ฐ€ ์žˆ์œผ๋ฉด ํ”ผํ•˜์ˆ˜์•ก
8-10 %- ์ถ”๊ฐ€์ ์œผ๋กœ ๋งฅ๋ฐ•์ด ์•ฝํ•˜๊ณ  ๋น ๋ฅด๋ฉฐ, ๋ˆˆ ์ฃผ์œ„๊ฐ€ ๊บผ์ ธ ๋ณด์ผ ๋•Œ
โ‡’ 8% ์ด์ƒ์ด๋ฉด ์ „์‹  ์ฆ์ƒ ๋™๋ฐ˜, ๋ฐ˜๋“œ์‹œ ์ •๋งฅ์„ ํ†ตํ•œ ํƒˆ์ˆ˜ ๊ต์ •
> 10%- ์ถ”๊ฐ€๋กœ ํ™˜์ž์˜ mental ๊ฐ์†Œ (๋ฐ˜์‘ ์ง€์—ฐ ๋“ฑ)
โ‡’ ์ •๋งฅ์— ์˜ํ•œ ํƒˆ์ˆ˜ ๊ต์ •, ๊ธฐ์ € ์งˆํ™˜ ์น˜๋ฃŒ ์‹œ๊ธ‰

ํ•˜๋ถ€ ์†Œํ™”๊ธฐ ์งˆํ™˜

3.1 Acute enteritis (๊ธ‰์„ฑ ์žฅ์—ผ)

Etiology

  • ์ „์—ผ์„ฑ ๋ฌผ์งˆ, ์œ„์ƒ ์ƒํƒœ ๋ถˆ๋Ÿ‰ํ•œ ์‹์ด, ๊ฐ‘์ž‘์Šค๋Ÿฌ์šด ์‹์ด ๋ณ€ํ™”, ๋ถ€์ ์ ˆํ•œ ์‹์ด, ํ™”ํ•™ ๋ฌผ์งˆ, ๊ธฐ์ƒ์ถฉ ๋“ฑ
  • ๊ธ‰์„ฑ ์„ค์‚ฌ๋ฅผ ๋ณด์ด๋Š” ๊ฒฝ์šฐ, ์•„๋ž˜ ๋ฌธ์ง„
    • ์ตœ๊ทผ ๋ณ‘์›์— ์ž…์›ํ•œ ๋ณ‘๋ ฅ
    • ์“ฐ๋ ˆ๊ธฐํ†ต์„ ๋’ค์ง„ ํ”์ 
    • ์ตœ๊ทผ ์‹์ด ๋ณ€ํ™”
    • ๋ฌธ์ง„์ƒ ํŒŒ๋ณด, ๊ธฐ์ƒ์ถฉ, ์‹์ด๋ณ€ํ™” ๋“ฑ์ด ํ™•์ธ๋˜์ง€ ์•Š๋Š”๋‹ค๋ฉด, ์›์ธ์ด ๋ชจํ˜ธํ•˜๋ฏ€๋กœ ์›์ธ์ด ์ง„๋‹จ๋˜๋Š” ๊ฒฝ์šฐ๋Š” ๋“œ๋ฌพ
  • ๊ธ‰์„ฑ ์žฅ์—ผ์˜ ๊ฒฝ์šฐ, ํŠน๋ณ„ํ•œ ์ฒ˜์น˜ ์—†์ด ํšŒ๋ณต๋จ. ๋ณ‘๋ ฅ์ด ์ค‘์š”ํ•˜์ง€ ์ถ”๊ฐ€์ ์ธ ๊ฒ€์‚ฌ๋Š” ๋“œ๋ฌผ๋‹ค.

Clinical Features

  • ์„ค์‚ฌ : ํŠนํžˆ ์–ด๋ฆฐ ๊ฐœ/๊ณ ์–‘์ด์—์„œ ์›์ธ ๋ถˆ๋ช…์˜ ๊ธ‰์„ฑ ์„ค์‚ฌ๋Š” ํ”ํ•จ.
  • ๊ตฌํ† , ํƒˆ์ˆ˜
  • ๋ฐœ์—ด, ์‹์š• ๋ถ€์ง„
  • ๊ธฐ๋ ฅ ์ €ํ•˜
  • ์šธ๋ถ€์ง–์Œ (crying)
  • ๋ณตํ†ต
  • ์ €์ฒด์˜จ(hypothermic), ์ €ํ˜ˆ๋‹น(hypoglycemic), ์˜์‹์ €ํ•˜(stupor) : ์•„์ฃผ ์–ด๋ฆฐ ๊ฒฝ์šฐ ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Œ
    • ํ˜ˆ๋‹น์„ ํฌํ•จํ•œ ์ƒํƒœ ํ‰๊ฐ€๋ฅผ ๊ผผ๊ผผํ•˜๊ฒŒ.

Diagnosis

  • ์‹ฌ๊ฐ๋„๊ฐ€ ํฌ์ง€ ์•Š์œผ๋ฏ€๋กœ ๋น„์šฉ์ด ๋งŽ์ด ๋“ค์ง€ ์•Š๋Š” ์•„๋ž˜ 3๊ฐ€์ง€ ๊ฒ€์‚ฌ๊นŒ์ง€ ๋งŽ์ด ํ•จ.
  • ๋ฌธ์ง„, ์‹ ์ฒด ๊ฒ€์‚ฌ, ๋ถ„๋ณ€ ๊ฒ€์‚ฌ (์›์ธ ํ™•์ธ)
    • Fecal flotation (๋ถ€์œ  ๊ฒ€์‚ฌ) : zinc sulfate solution์„ ์ด์šฉ, ๋ณ€๊ณผ ์„ž์–ด์„œ ์›์‹ฌ๋ถ„๋ฆฌํ•˜๋ฉด ์ถฉ๋ž€์ด ์œ„๋กœ ๋– ์˜ค๋ฆ„. ์ƒ์ธต์— ๊ฒ€๊ฒฝํ•˜์—ฌ ๊ธฐ์ƒ์ถฉ ํ‰๊ฐ€. ์„ค์‚ฌ ํ™˜์ž์—์„œ๋Š” ํ•„์ˆ˜! (๊ธฐ์ƒ์ถฉ ๊ฐ์—ผ์ด ๋™๋ฐ˜๋˜๋ฉด ์ฆ์ƒ ์•…ํ™”)
    • Direct fecal examination (์ง์ ‘ ๋„๋ง๋ฒ•) : ์„ธ๊ท  ๊ฒ€๊ฒฝ
    • Fecal ELISA : ์–ด๋ฆฐ ํ™˜์ž์—์„œ, canine parvovirus ํ‚คํŠธ ๊ฒ€์‚ฌ ์ถ”์ฒœ.

  • ์งˆํ™˜์ด ์‹ฌํ•˜๊ณ  ๊ฐ์—ผ ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์œผ๋ฉด ์•„๋ž˜ ๊ฒ€์‚ฌ๋„ ๊ฐ€๋Šฅ (๋ฐœ์—ด, ํ˜ˆ๋ณ€์ด๋‚˜ ํ‘๋ณ€, ์žฅ์—ผ์˜ ์ง‘๋‹จ ๋ฐœ๋ณ‘ ๋“ฑ)
    • CBC (neutropenia ํ™•์ธ) : ํŒจํ˜ˆ์ฆ ์ง„ํ–‰ ํ™•์ธ
    • Serologic analysis : ๊ณ ์–‘์ด์—์„œ FeLV, FIV ๊ฒ€์‚ฌ
    • Blood glucose (hypoglycemia) : ์ €ํ˜ˆ๋‹น ํ™•์ธ
    • Serum electrolytes (hypokalemia) : ์นผ๋ฅจ์ด ๋‚ฎ์œผ๋ฉด ์‹์š•์ด ๋–จ์–ด์ง€๊ณ  ์œ„์žฅ๊ด€ ์šด๋™์„ฑ ์ €ํ•˜, ๋„ˆ๋ฌด ๋‚ฎ์œผ๋ฉด ์น˜๋ช…์ ์ธ ๋ถ€์ •๋งฅ - ํ•„์š” ์‹œ ์นผ๋ฅจ ๊ธ‰์—ฌ ๋˜๋Š” ํˆฌ์•ฝ
    • ๋ณต๋ถ€ ๋ฐฉ์‚ฌ์„ , ์ดˆ์ŒํŒŒ : ๋ณต๋ถ€ ํ†ต์ฆ, ์ด๋ฌผ, ์ข…๊ดด, ํ์ƒ‰ ๊ฒ€์‚ฌ๊ฐ€ ํ•„์š”ํ•  ๋•Œ

Treatment

  • Symptomatic therapy : ๋ณดํ†ต ๋Œ€์ฆ ์น˜๋ฃŒ๋กœ ์ถฉ๋ถ„
    • ํƒˆ์ˆ˜ ๊ต์ •, ์ „ํ•ด์งˆ/์‚ฐ์—ผ๊ธฐ ๋ถˆ๊ท ํ˜• ๊ต์ • ๋ชฉ์ 
    • > 8% dehydration โ†’ IV fluids
    • < 8% dehydration โ†’ PO/SC fluids
    • hypokalemia โ†’ Potassium supplementation (์ˆ˜์•ก์— ํƒ€์„œ/๊ฒฝ๊ตฌ๋กœ)
    • Bicarbonate : ์„ค์‚ฌ๋กœ ์ธํ•ด ์ค‘ํƒ„์‚ฐ๋„ ๋น ์งˆ ์ˆ˜ ์žˆ์Œ, ํ•„์š” ์‹œ ํˆฌ์—ฌ

  • Antidiarrheals (์ง€์‚ฌ์ œ)
    • ์ž˜ ์‚ฌ์šฉํ•˜์ง€ ์•Š์Œ. ํŒจํ˜ˆ์ฆ์ด๋‚˜, ๋…์†Œ๋ฅผ ์œ ๋ฐœํ•˜๋Š” ์„ธ๊ท ์— ๊ฐ์—ผ๋œ ์ƒํƒœ๋ผ๋ฉด ์ฆ์ƒ์ด ์•…ํ™”๋  ์ˆ˜ ์žˆ์Œ. ๊ธ‰์„ฑ ์žฅ์—ผ์€ ๊ฒ€์‚ฌ๋ฅผ ๋งŽ์ด ์•ˆ ํ•˜๋Š” ๊ฒฝํ–ฅ โ†’ ์ถฉ๋ถ„ํ•œ ๊ฒ€์‚ฌ๋กœ ๊ฐ์—ผ์„ฑ ์„ค์‚ฌ๋ฅผ ๋ฐฐ์ œํ•œ ๊ฒฝ์šฐ๊ฐ€ ์•„๋‹ˆ๋ผ๋ฉด ์‚ฌ์šฉ์— ์ฃผ์˜.
    • ํˆฌ์•ฝํ•˜๋”๋ผ๋„ 2-5์ผ ์ด์ƒ X
์ง€์‚ฌ์ œ
loperamide- Opiates (opiods), ์žฅ ์šด๋™ ์–ต์ œ.
- ์•„ํŽธ๋ฅ˜์ง€๋งŒ ์ง„ํ†ต๋ณด๋‹ค๋Š” ์žฅ ์—ฐ๋™์šด๋™ ์–ต์ œ ๋ชฉ์ ์œผ๋กœ ๋งŽ์ด ์‚ฌ์šฉ๋จ. BBB ํ†ต๊ณผ X โ†’ ์ง„์ • ์ž‘์šฉ์€ ๊ฑฐ์˜ ์—†์Œ.
- ๋ณ€์„ ์žฅ ์•ˆ์— ์˜ค๋ž˜ ๋จธ๋ฌด๋ฅด๊ฒŒ ํ•ด ์ˆ˜๋ถ„ ํก์ˆ˜ ์‹œ๊ฐ„ โ†‘, ์„ค์‚ฌ ์™„ํ™”.
- ๊ฐœ์—์„œ ํšจ๊ณผ์ 
โ›” Contraindications โ›”
- ๊ณ ์–‘์ด (๋Œ€์‚ฌ ๋Šฅ๋ ฅ ๋‚ฎ์Œ)
- Collies/Shetland sheepdog (MDR1 ์œ ์ „์ž ๋Œ์—ฐ๋ณ€์ด๋กœ ์•ฝ๋ฌผ ๋Œ€์‚ฌ์— ๋ฌธ์ œ)
- Infection (์ „์—ผ์„ฑ ์„ค์‚ฌ์—์„œ ์žฅ ์•ˆ์— ๋ณ€์ด ์˜ค๋ž˜ ๋จธ๋ฌด๋ฅด๊ฒŒ ๋˜๋ฉด ๋…์†Œ ํก์ˆ˜ ์ฆ๊ฐ€)
bismuth subsalicylate- Astringents(์ˆ˜๋ ด์ œ) : ์žฅ ์ ๋ง‰์„ ์ˆ˜์ถ•์‹œ์ผœ ์žฅ์˜ ์—ผ์ฆ์„ฑ ๋ถ„๋น„๋ฌผ์„ ๊ฐ์†Œ์‹œํ‚ด.
- ์ค‘๋“ฑ๋„์˜ ์žฅ์—ผ์—์„œ ์—ผ์ฆ์„ ์ค„์ผ ๋ชฉ์ ์œผ๋กœ ์‚ฌ์šฉ
- ์‹ ๋…์„ฑ์„ ๊ฐ€์ง - ์‹ ์žฅ์—์„œ ๋ฐฐ์„ค๋˜๋Š” ๋‹ค๋ฅธ ์•ฝ๋ฌผ(ํ€ด๋†€๋ก  ๋“ฑ)๊ณผ ๋ณ‘์šฉ ๊ธˆ์ง€
- ๊ฐ•์•„์ง€๊ฐ€ ์‹ซ์–ดํ•˜๋Š” ๋ง›, ํˆฌ์•ฝ์ด ์–ด๋ ค์›€
โ›” Contraindications โ›”
- ๊ณ ์–‘์ด (salicylate ๊ณ„์—ด์˜ ๋Œ€์‚ฌ์— ๋ฏผ๊ฐํ•จ, ์ค‘๋…(โ†’๊ตฌํ† , ๋ฌด๊ธฐ๋ ฅ, ๊ฐ„๋…์„ฑ, ํ˜ธํก๋ถ€์ „) ๊ฐ€๋Šฅ์„ฑ์ด ์žˆ์Œ, ์™„์ „ ๊ธˆ๊ธฐ!)
์žฅ ํก์ฐฉ์ œKaolin-pectin, Smectite, ํ™œ์„ฑํƒ„(activated charcoal)
- ๊ณผ๋„ํ•œ ์ˆ˜๋ถ„, gas ๋“ฑ์„ ํก์ฐฉํ•˜์—ฌ ๋ฐฐ์ถœ
- ๋น„๊ต์  ์•ˆ์ „ํ•จ.
  • Probiotics : ๊ณ ์–‘์ด์˜ ์ŠคํŠธ๋ ˆ์Šค์„ฑ ์„ค์‚ฌ์—์„œ ํšจ๊ณผ ์ข‹์Œ
  • Antiemetics (ํ•ญ๊ตฌํ† ์ œ) : ์ˆ˜๋ถ„ ์†Œ์‹ค ๋ฐฉ์ง€ (์žฅ์—ผ์ด ์‹ฌํ•˜๋ฉด ์œ„๋„ ์˜ํ–ฅ์„ ๋ฐ›์•„ ๋ฉ”์Šค๊บผ์›€, ๊ตฌํ†  ๋‚˜ํƒ€๋‚จ)
    • Peripheral-acting < Central-acting (์ค‘์ถ”์„ฑ ํ•ญ๊ตฌํ† ์ œ) : maropitant, ondansetron

  • Dietary
    • Withhold the feed (๊ธˆ์‹)
      • but ์™„์ „ ๊ธˆ์‹ โ†’ ์žฅ์ ๋ง‰์˜ ์˜์–‘๋ถ„๋„ ์—†์–ด์ง, ์žฅ์ ๋ง‰ ์„ธํฌ ์†์ƒ ๊ฐ€๋Šฅ
      • ์ตœ๊ทผ์—” ์†Œ๋Ÿ‰์ด๋ผ๋„ ์Œ์‹์„ ํˆฌ์—ฌํ•˜๋Š” ๊ฒƒ์ด ํšŒ๋ณต์— ์ข‹๋‹ค๊ณ  ์•Œ๋ ค์ง. (์กฐ๊ธˆ๋งŒ ๋จน์–ด๋„ ํญ๋ฐœ์ ์ธ ๊ตฌํ† ๋กœ ์ˆ˜๋ถ„์ด ๋” ์†Œ์‹ค๋˜๋Š” ๊ฒŒ ์•„๋‹ˆ๋ผ๋ฉด..)
    • ์†Œ๋Ÿ‰์”ฉ ์—ฌ๋Ÿฌ ๋ฒˆ, ์ž๊ทน์ด ์—†๋Š” ์Œ์‹ ํˆฌ์—ฌ (cottage cheese, ์‚ถ์€ ๋‹ญ๊ณ ๊ธฐ, ๊ฐ์ž)
    • ์ •์ƒ ์‹์ด ํšŒ๋ณต๊นŒ์ง€ 5-10์ผ ์ •๋„ : ๊ธˆ์‹ ์˜ค๋ž˜ ์œ ์ง€ํ•˜์ง€ ์•Š๊ณ  ๊ฐ€๋Šฅํ•œ ๋นจ๋ฆฌ ์Œ์‹ ๊ธ‰์—ฌ. ์—ฌ์ „ํžˆ ์„ค์‚ฌ๊ฐ€ ๋ฐœ์ƒํ•œ๋‹ค๋ฉด, 5์ผ ์ •๋„ ๋’ค ๋‹ค์‹œ ์‹œ๋„.
    • ๋“œ๋ฌผ๊ฒŒ ๋น„๊ฒฝ๊ตฌ ์˜์–‘ ์ˆ˜์•ก(Parenteral nutrition) ํ•„์š” : ์•„์ฃผ ์–ด๋ฆฐ ๋™๋ฌผ์—์„œ ์ €ํ˜ˆ๋‹น โ†’ dextrose administration

  • Broad-Spectrum systemic antibiotics
    • ์›์ธ์ด ๋ฐํ˜€์ง€์ง€ ์•Š์œผ๋ฉด โ†’ ์ถ”๊ฐ€์ ์ธ ๊ฒ€์‚ฌ๋ณด๋‹จ ๊ฐ์—ผ์„ฑ์œผ๋กœ ๊ฐ„์ฃผํ•˜๊ณ  ์ค€ํ•ด์„œ ์น˜๋ฃŒ
    • Indications | ๋ฐœ์—ด, neutropenic, SIRS ๊ด€๋ จ ์ˆ˜์น˜ (CRP ์ƒ์Šน, ํ˜ˆ๋‹น ๊ฐ์†Œ, globulin ์ƒ์Šน) ๋“ฑ
    • ฮฒ-lactam ๊ณ„ํ†ต + Aminoglycoside/fluoroquinolones (โ‡’ sepsis ๋ฐฉ์ง€)
  • Disinfection : ํŒŒ๋ณด ์–‘์„ฑ์— ์˜ํ•œ ๊ธ‰์„ฑ ์žฅ์—ผ์ด๋ผ๋ฉด, ์ ‘์ด‰ํ•œ ๋‹ค๋ฅธ ์‚ฌ๋žŒ์ด๋‚˜ ๋™๋ฌผ, ์ผ€์ด์ง€ ๋“ฑ์„ ๋ฝ์Šค ์†Œ๋….

Prognosis

  • ํ™˜์ž์˜ ๋‚˜์ด, ์ปจ๋””์…˜, ๋‹ค๋ฅธ ์†Œํ™”๊ธฐ ์ฆ์ƒ์— ๋”ฐ๋ผ ๋‹ฌ๋ผ์ง
  • ์˜ˆํ›„ ์•…ํ™”์˜ ํ‘œ์ง€
    • very young
    • emaciated animals (์‡ ์•ฝ - ์˜์–‘ ๊ฒฐํ•, ๊ตฌ์กฐ๋œ ํ™˜์ž)
    • SIRS, sepsis๋กœ ์ง„ํ–‰
    • Intestinal parasite - ์žฅ๋‚ด ๊ธฐ์ƒ์ถฉ ๊ณผ๋„ํ•˜๊ฒŒ ์ฆ์‹
    • Intussusception : ์žฅ์—ผ์ด ๋„ˆ๋ฌด ์‹ฌํ•ด ์—ฐ๋™ ์šด๋™์ด ๋นจ๋ผ์ง€๋ฉด ์žฅ์ด ์žฅ ์‚ฌ์ด๋กœ ์ค‘์ฒฉ โ†’ ์žฅ์˜ ๊ดด์‚ฌ, ์˜ˆํ›„ ์•„์ฃผ ๋ถˆ๋Ÿ‰
  • ๋Œ€๋ถ€๋ถ„์€ ์›์ธ์ด ๋ฐํ˜€์ง€์ง€ ์•Š์•„๋„ ๋Œ€์ฆ ์น˜๋ฃŒ, ์ž๊ฐ€ ํšŒ๋ณต

3.2 Enterotoxemia (์žฅ๋…์†Œํ˜ˆ์ฆ)

Etiology

  • ์›์ธ์€ ์„ธ๊ท ์ผ ๊ฒƒ์œผ๋กœ ์ถ”์ •
  • ์›์ธ์ฒด๊ฐ€ ๋ถ„๋ฆฌ๋˜๋Š” ๊ฒฝ์šฐ๋Š” ๊ฑฐ์˜ ์—†์Œ
  • ์ž„์ƒ ์ฆ์ƒ๊ณผ ๋‹ค๋ฅธ ๊ฒ€์‚ฌ๋ฅผ ์ข…ํ•ฉํ•ด์„œ ์ง„๋‹จ

Clinical Features

  • Acute onset
  • Severe diarrhea with vomiting (often mucoid-bloody diarrhea) : ์•„์ฃผ ์‹ฌํ•œ ๊ตฌํ†  ์„ค์‚ฌ์—, ์ ์•ก-ํ˜ˆ์•ก์ด ํ˜ผ์ž…, ์‹ฌํ•œ ๊ฒฝ์šฐ ์žฅ ์ ๋ง‰๋„ ๊ฐ™์ด ๋ฐฐ์ถœ
  • Ill : ์ „์‹  ์‡ ์•ฝ ์ฆ์ƒ (๋ฐœ์—ด, ๊ธฐ๋ ฅ ์ €ํ•˜ ๋“ฑ; ๊ธ‰์„ฑ ์žฅ์—ผ๊ณผ ๋Œ€๋น„๋˜๋Š” ์ )
  • Shock : ์•„์ฃผ ์ดˆ๊ธฐ์—๋„ ์‡ผํฌ ์ฆ์ƒ์ด ๋‚˜ํƒ€๋‚  ์ˆ˜ ์žˆ์Œ

Diagnosis

  • ๋ณ‘๋ ฅ๊ณผ ์‹ ์ฒด ๊ฒ€์‚ฌ๋กœ ๋‹ค๋ฅธ ์งˆ๋ณ‘ ๋ฐฐ์ œ
  • CBC ๊ฒ€์‚ฌ์ƒ Neutrophilic leukocytosis (ํŠน์ง•์ )
    • Neutrophil์˜ Left shift, toxic change๋„ ํ•จ๊ป˜ ๊ด€์ฐฐ๋  ์ˆ˜ ์žˆ์Œ
  • ์žฅ๋‚ด ๊ธฐ์ƒ์ถฉ์ด ๋™๋ฐ˜ ๊ฐ์—ผ๋˜์—ˆ๋Š”์ง€ ํ™•์ธ
  • ์„ธ๊ท  ๋ฐฐ์–‘ ๊ฒ€์‚ฌ๋Š” ์œ ์šฉํ•˜์ง€ ์•Š์Œ

Treatment

  • ๊ณต๊ฒฉ์ ์ธ IV fluid therapy : ์‹ฌํ•œ ๊ตฌํ†  ์„ค์‚ฌ๋กœ ์‡ผํฌ ์œ„ํ—˜
  • ๊ด‘๋ฒ”์œ„ ํ•ญ์ƒ์ œ ์ฒ˜์น˜ (AMC)
  • Hypoalbuimnemia โ†’ Colloids : ํ˜ˆ์ฒญ ์•Œ๋ถ€๋ฏผ ์ˆ˜์น˜ ๋ชจ๋‹ˆํ„ฐ๋ง ํ•ด์„œ ํ•„์š”ํ•˜๋ฉด colloids ์ˆ˜์•ก ํˆฌ์—ฌ (๐Ÿ”—์‘๊ธ‰(B) - 3. Fluid therapy ํ›„๋ฐ˜)
  • DIC ์ง„ํ–‰ ํ™•์ธ (์‹ฌํ•œ ๊ด‘๋ฒ”์œ„ ์—ผ์ฆ์œผ๋กœ ์‘๊ณ ์ธ์ž๊ฐ€ ํ™œ์„ฑํ™”๋˜๋ฉด์„œ DIC ๋ฐœ์ƒ ๊ฐ€๋Šฅ)
    • ์‘๊ณ ์ธ์ž ๋ณด์ถฉ ํ•„์š” โ†’ Plasma
    • ํ˜ˆ์ „ ์šฐ์„ธ, ์ถœํ˜ˆ ์—†์Œ, ํ˜ˆ์ „์— ์˜ํ•œ ์žฅ๊ธฐ ํ—ˆํ˜ˆ์˜ ์ง•ํ›„ โ†’ Heparin therapy

Prognosis

  • ๋‚ด์› ๋‹น์‹œ ์ง„ํ–‰๋„์— ๋”ฐ๋ผ ๋‹ค๋ฆ„
  • Shock, DIC๋ถ€ํ„ฐ ์น˜๋ฃŒ ์‹œ์ž‘ํ•œ๋‹ค๋ฉด ์˜ˆํ›„๊ฐ€ ์ข‹์ง€ ์•Š์Œ
  • ์ดˆ๊ธฐ์— ์ ์ ˆํ•œ ์น˜๋ฃŒ๋ฅผ ๋ฐ›์œผ๋ฉด(ํ•ญ์ƒ์ œ, ์ˆ˜์•ก) ํšŒ๋ณต ๊ฐ€๋Šฅ

3.3 Dietary-induced diarrhea (์‹์ด์„ฑ ์„ค์‚ฌ)

Etiology

  • ์–ด๋ฆฐ ๋™๋ฌผ์—์„œ ์‹์ด์— ์˜ํ•œ ์„ค์‚ฌ ํ”ํ•จ
  • ์ƒํ•œ ์Œ์‹ ์„ญ์ทจ (Rancid fat; ์ง€๋ฐฉ์ด ์‚ฐํŒจํ•œ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Œ)
  • Bacterial enetrotoxins(์„ธ๊ท ์— ์˜ํ•œ ๋‚ด๋…์†Œ), Mycotoxins(์ง„๊ท ๋…์†Œ)์— ๊ฐ์—ผ๋œ ์Œ์‹
  • Food allergy, intolerance : ์žฅ์ด ์ƒˆ๋กœ์šด ์Œ์‹์— ์ ์‘ํ•˜๊ธฐ๊นŒ์ง€ ์˜์–‘์†Œ ํก์ˆ˜/์†Œํ™”๋ฅผ ๋ชปํ•ด์„œ
  • ์ •์ƒ ์‹์ด๋ฅผ ์†Œํ™”ํ•˜์ง€ ๋ชปํ•˜๋Š” ๊ฒฝ์šฐ
  • ์ƒˆ๋กœ์šด ์‹์ด์— ๋ฐ˜์‘
  • Digest enzyme deficiency - Lactose intolerance (์šฐ์œ  ๋ถ„ํ•ด ํšจ์†Œ๊ฐ€ ๋ถ„๋น„๋˜์ง€ X)

Clinical Features

  • ๊ฐœ์™€ ๊ณ ์–‘์ด ๋ชจ๋‘์—์„œ ๋ฐœ์ƒ
  • ์†Œ์žฅ์„ฑ ์„ค์‚ฌ๋ฅผ ๋‚˜ํƒ€๋‚ด๋Š” ๊ฒฝํ–ฅ
    • ํ˜ˆ์•ก์ด๋‚˜ ์ ์•ก์€ ์ž˜ ์„ž์ด์ง€ ์•Š์Œ (๊ฒฐ์žฅ์—ผ์ด ๋™๋ฐ˜๋œ ๊ฒฝ์šฐ ์˜ˆ์™ธ)
  • New diet์— ๋Œ€ํ•ด 1-3์ผ ๋’ค ๋ฐœ์ƒ
  • ๊ฒฝ๋ฏธ์—์„œ ์ค‘๋“ฑ๋„ ์ •๋„
  • ๋‹ค๋ฅธ ์ฆ์ƒ์ด ๋™๋ฐ˜๋˜๋Š” ๊ฒฝ์šฐ๋Š” ๋“œ๋ฌพ

Diagnosis

  • ๋‹ค๋ฅธ ์›์ธ์„ ๋ฐฐ์ œ
    • ๋ณ‘๋ ฅ ์ฒญ์ทจ, ์‹ ์ฒด ๊ฒ€์‚ฌ, ๋ถ„๋ณ€ ๊ฒ€์‚ฌ
  • โ€˜์‹์ด ๋ณ€ํ™”๊ฐ€ ์ƒ๊ธด ์ดํ›„๋กœ ๋น ๋ฅธ ์‹œ์ผ ๋‚ด์— ์‹œ์ž‘๋œ ์„ค์‚ฌโ€™ โ†’ ์ด๊ฒƒ๋งŒ์œผ๋กœ ์˜์‹ฌ ๊ฐ€๋Šฅ

Treatment

  • Bland diet : ๊ฐ„์ด ์•ˆ ๋œ ๋‹ด๋ฐฑํ•œ ์‚ฌ๋ฃŒ ๊ธ‰์—ฌ (์‚ถ์€ ๊ฐ์ž, ๊ธฐ๋ฆ„๊ธฐ๋ฅผ ์ œ๊ฑฐํ•œ ๋‹ญ๊ณ ๊ธฐ)
  • ์‹์ด๋ฅผ ๋ฐ”๊พธ๊ณ  ์†Œ๋Ÿ‰์”ฉ ๊ธ‰์—ฌํ•˜๋Š” ๊ฒƒ๋งŒ์œผ๋กœ๋„ 1-3์ผ ๋‚ด ํ˜ธ์ „
  • ์„ค์‚ฌ๊ฐ€ ๋ฉˆ์ถ”๋ฉด ์ฒœ์ฒœํžˆ ๊ธฐ์กด ์‚ฌ๋ฃŒ๋กœ ๋ณต๊ท€

Prognosis

  • ์•„์ฃผ ์–ด๋ ค์„œ ์ €ํ˜ˆ๋‹น์ด ์˜ค๋Š” ๊ฒฝ์šฐ๋งŒ ์•„๋‹ˆ๋ผ๋ฉด, ์˜ˆํ›„๋Š” ์ข‹์Œ (Excellent)

3.4 Exocrine pancreatic insufficiency (EPI, ์™ธ๋ถ„๋น„ ์ทŒ์žฅ ๋ถ€์ „)

Etiology

  • ์ทŒ์žฅ โ†’ ๋‚ด๋ถ„๋น„ ๊ธฐ๋Šฅ (Insulin ๋ถ„๋น„), ์™ธ๋ถ„๋น„ ๊ธฐ๋Šฅ (์†Œํ™”ํšจ์†Œ ๋ถ„๋น„)
  • ์ทŒ์žฅ์—ผ โ†’ ์ทŒ์žฅ์˜ ์„  ์„ธํฌ ์œ„์ถ•/ํŒŒ๊ดด โ†’ ์†Œํ™”ํšจ์†Œ ๋ถ„๋น„X
    • ๋ฉด์—ญ๋งค๊ฐœ์„ฑ or ํŠน๋ฐœ์„ฑ ๋“ฑ
  • ๊ฐœ์—์„œ ๋ฐœ์ƒ / ๊ณ ์–‘์ด์—์„œ rare
  • ์†Œํ™”ํšจ์†Œ ๋ถ€์กฑ์œผ๋กœ ํก์ˆ˜ ๊ธฐ๋Šฅ ์žฅ์• , ๋ฐฅ์€ ๊ณ„์† ๋จน๋Š”๋ฐ ๊ฐˆ์ˆ˜๋ก ์‚ด์ด ์‹ฌํ•˜๊ฒŒ ๋น ์ง

Clinical Features

  • ์ „ํ˜•์ ์ธ ๋งŒ์„ฑ ์†Œ์žฅ์„ฑ ์„ค์‚ฌ (Fecal score 6-7)
  • Ravenous appetite (๊ตถ์ฃผ๋ฆฐ ๊ฒƒ์ฒ˜๋Ÿผ ์—„์ฒญ๋‚œ ์‹ํƒ) but ์ฒด์ค‘ ๊ฐ์†Œ
  • Steatorrhea (์ง€๋ฐฉ๋ณ€, ์ง€๋ฐฉ์ด ์†Œํ™”๋˜์ง€ ์•Š๊ณ  ๋ณ€์œผ๋กœ ๋‚˜์˜ด)
  • โ€˜์‹์š• ์ฆ๊ฐ€ + ์ฒด์ค‘ ๊ฐ์†Œโ€™ ๋งŒ ๋‚˜ํƒ€๋‚˜๊ธฐ๋„ ํ•จ. ์„ค์‚ฌ๊ฐ€ ์—†์–ด๋„ EPI ๋ฐ˜๋“œ์‹œ ๊ณ ๋ ค.

Diagnosis

  • ์‹ ์ฒด ๊ฒ€์‚ฌ, ์ผ๋ฐ˜์ ์ธ ์ž„์ƒ๋ณ‘๋ฆฌ ๊ฒ€์‚ฌ (โ‡’ ๋น„ํŠน์ด์  ๊ฒฐ๊ณผ)
  • ์ทŒ์žฅ ์†Œํ™” ํšจ์†Œ๊ฐ€ ๋ถ€์กฑํ•œ ๊ฒƒ์„ ํ™•์ธํ•˜๊ธฐ ์œ„ํ•ด ์†Œํ™” ํšจ์†Œ ๊ฒ€์‚ฌ
    • TLI or PLI, ์ด ์ค‘ EPI ์ง„๋‹จ์—๋Š” TLI๊ฐ€ ์ •ํ™•๋„ โ†‘, ๋ฏผ๊ฐ๋„ โ†‘
    • TLI (serum Trypsin-Like Immunoreactivity) : ๋‚ฎ์œผ๋ฉด EPI๋กœ ์ง„๋‹จ ๊ฐ€๋Šฅ
    • cPLI/fPLI (canine/feline Pancreatic Lipase Immunoreactivity) : PLI๊ฐ€ ๋‚ฎ์œผ๋ฉด EPI, but ๊ฐ„ํ˜น ์ •์ƒ์œผ๋กœ ๋‚˜์˜ค๊ธฐ๋„ ํ•จ. ์ทŒ์žฅ์—ผ์˜ ๋ณ‘๋ฐœ์„ ํ™•์ธํ•˜๊ธฐ ์œ„ํ•จ์ด์ง€, EPI ์ง„๋‹จ์— specificํ•˜์ง€๋Š” ์•Š์Œ.

Treatment

  • Pancreatic enzymes with food : ์†Œํ™”ํ•  ์ˆ˜ ์žˆ๋„๋ก ์ทŒ์žฅ ํšจ์†Œ๋ฅผ ํ•จ๊ป˜ ๋จน์ž„.
    • ์ด๋ฏธ ์„ ์„ธํฌ์˜ ์œ„์ถ•์ด ์ผ์–ด๋‚จ โ†’ ํšŒ๋ณต์ด ๋˜๋Š” ๊ฑด ์•„๋‹ˆ๊ณ , ํ‰์ƒ ์†Œํ™” ํšจ์†Œ ํˆฌ์•ฝ ํ•„์š”
    • Pancreatin powder 1 teaspoon/dog(10kg) OR Lypex capsule 1 capsule/dog(10kg) PO with meals
  • ์‹œ๊ฐ„์ด ๊ฑธ๋ฆฌ๋Š” ์น˜๋ฃŒ์ž„์„ ๋ณดํ˜ธ์ž์—๊ฒŒ ์ž˜ ์•ˆ๋‚ด

์†Œํ™”๊ฐ€ ์•ˆ ๋œ ์Œ์‹์ด ์žฅ ์•ˆ์—์„œ ๋ถ€ํŒจํ•˜๋ฉด์„œ ์žฅ๋‚ด ๊ณผ๋„ํ•œ ์„ธ๊ท  ์ฆ์‹์ด ์ผ์–ด๋‚  ์ˆ˜ ์žˆ์Œ. ์„ธ๊ท ์„ฑ ์žฅ์—ผ์˜ ๋ณ‘๋ฐœ์„ ํ‰๊ฐ€ํ•˜์—ฌ ์ถ”๊ฐ€์ ์ธ ํ•ญ์ƒ์ œ ์ฒ˜์น˜ ํ•„์š”. (= ARE)

์‹ค์ œ case ์น˜๋ฃŒ ๊ฒฝ๊ณผ

  • ์ฒซ๋‚  BCS 1 - 1๊ฐœ์›” ๋’ค BCS 2 - 3๊ฐœ์›” ๋’ค BCS 2-3
  • ์ฒซ๋‚  Fecal score 6 - 7์ผ ์ •๋„์— ๊ฑธ์ณ ์ ์ฐจ ์ •์ƒ๋ณ€์œผ๋กœ๊นŒ์ง€ ํšŒ๋ณต

3.5 Antibiotic-responsive enteropathy (ARE = SIBO)

Synonym

  • Antibiotic-Responsive Enteropathy (ARE, ํ•ญ์ƒ์ œ ๋ฐ˜์‘์„ฑ ์žฅ๋ณ‘์ฆ)
  • Antibiotic-responsive diarrhea (ํ•ญ์ƒ์ œ ๋ฐ˜์‘์„ฑ ์„ค์‚ฌ)
  • Small Intestinal Bacterial Overgrowth (SIBO, ์†Œ์žฅ์„ฑ ์„ธ๊ท  ๊ณผ์ฆ์‹)
  • Dysbiosis

Definition

  • Duodenum +/- jejunum has high numbers of bacteria : ์‹ญ์ด์ง€์žฅ~๊ณต์žฅ ๋ถ€๋ถ„์˜ ์ •์ƒ ์„ธ๊ท ์ด์ด ์†Œํ™”๊ฐ€ ์•ˆ ๋œ ์Œ์‹๋ฌผ์„ ์—ฐ๋ฃŒ๋กœ ์‚ผ์•„ ์ฆ์‹ํ•˜๋Š” ๊ฒƒ
    • ๋ณ‘์ ์ธ ์„ธ๊ท , ๋…์†Œ ๋ถ„๋น„ ์„ธ๊ท ์ด ๋” ์ฆ์‹ํ–ˆ๋‹ค๋ฉด ์ผ๋ฐ˜์ ์ธ ๊ฒฝ์šฐ๋ณด๋‹ค ๋” ์‹ฌํ•  ์ˆ˜ ์žˆ์Œ
    • ํ•ญ์ƒ์ œ๋กœ ์ž˜ ์น˜๋ฃŒ๋˜๊ธด ํ•˜์ง€๋งŒ, ์น˜๋ฃŒ ์‹œ๊ธฐ๋ฅผ ๋†“์น˜๋ฉด ์˜๊ตฌ์ ์ธ ์†Œํ™”์žฅ์• , ์Œ์‹๋ถˆ๋‚ด์ฆ ๋“ฑ ํ›„์œ ์ฆ์ด ๋‚จ์„ ์ˆ˜ ์žˆ์Œ

Etiology

  • Bacteria causing ARE
    • ์žฅ๋‚ด๊ท  ์ผ๋ถ€๊ฐ€ ํŠน์ • ์กฐ๊ฑด์— ์˜ํ•ด ๊ณผ์ฆ์‹
    • ์–ด๋–ค ์ข…๋ฅ˜๋“  ์ƒ๊ด€์—†์œผ๋‚˜ E. coli, Enterococci, Clostridium spp. ๋“ค์ด common
  • Secondary to EPI / IBD / IgA deficiency of German shepherd (์œ ์ „์ )
    • ์žฅ์˜ ๋‹ค๋ฅธ ์งˆํ™˜์— ์˜ํ•ด ์†Œํ™” ์žฅ์•  ๋˜๋Š” ์—ผ์ฆ์ด ์ƒ๊ฒจ ๊ทธ ๋ถ€๋ถ„์˜ ์„ธ๊ท  ๊ณผ์ฆ์‹

Clinical Features

  • ๋ชจ๋“  ํ’ˆ์ข…์˜ ๊ฐœ
  • ์„ค์‚ฌ๊ฐ€ ์ฃผ ์ฆ์ƒ, ์ฒด์ค‘ ๊ฐ์†Œ๊ฐ€ ๋™๋ฐ˜๋  ์ˆ˜ ์žˆ์Œ
  • ๊ตฌํ†  ๋™๋ฐ˜๋  ์ˆ˜ ์žˆ์Œ

Diagnosis

  • ๋ถ„๋ณ€ ์•ˆ์— ํŠน์ • ์„ธ๊ท ์ด ๋งŽ๊ฒ ์œผ๋‚˜, ๋ถ„๋ณ€์—๋Š” ์›๋ž˜ ์„ธ๊ท ์ด ๋งŽ์•„ ์ง„๋‹จ์  ๊ฐ€์น˜๊ฐ€ ๋–จ์–ด์ง. ์„œ๋กœ ์ƒํ˜ธ๋ณด์™„ํ•˜๋ฉด์„œ ์ง„๋‹จ.
  • (1) Quantitive duodenal fluid cultures : ๋‚ด์‹œ๊ฒฝ์œผ๋กœ ์†Œ์žฅ์•ก ๋ฐฐ์–‘, ์‹œ๋ฃŒ ์ถ”์ถœ์ด ์–ด๋ ต๋‹ค / ๋ถ„๋ณ€์˜ ๊ท ์ด ๋„ˆ๋ฌด ๋งŽ์•„ ๋”ฐ๋กœ ๋ฐฐ์–‘ํ•˜๊ธฐ๊ฐ€ ์–ด๋ ต๋‹ค๋Š” ๋‹จ์ ์ด ์žˆ์–ด ์ž„์ƒ์ ์œผ๋กœ๋Š” ์ž˜ ์‚ฌ์šฉ X
  • (2) Duodenal mucosal cytology & histopathology : ์‹ญ์ด์ง€์žฅ์ด๋‚˜ ์†Œ์žฅ์˜ ์ ๋ง‰์„ ๋‚ด์‹œ๊ฒฝ์œผ๋กœ ํš๋“, ์„ธํฌํ•™์ /์กฐ์งํ•™์  ๊ฒ€์‚ฌ.
    • LP ์—ผ์ฆ(lymphoplasmacytic infiltrates)์ด ๋ณด์ผ ๋ฟ, SIBO์˜ ํŠน์ง•์ ์ธ ์ง„๋‹จ์€ ์–ด๋ ต๊ณ , ์•” ๋“ฑ ๋‹ค๋ฅธ ์งˆ๋ณ‘์˜ ๋ฐฐ์ œ ๋ชฉ์ .
  • (3) Serum cobalamin and folate concentrations : ๊ฐ€์žฅ ๋งŽ์ด ์‚ฌ์šฉ. ํ˜ˆ์•ก ์•ˆ์—์„œ ์—ฝ์‚ฐ์˜ ๋†๋„๋ฅผ ์ธก์ •. ๋ฏผ๊ฐ๋„์™€ ํŠน์ด๋„๋Š” ๋‚ฎ์œผ๋‚˜, ๋น„์นจ์Šต์ ์ด๋ฉฐ ๋‹ค๋ฅธ ๊ฒ€์‚ฌ๋ณด๋‹ค ์ž„์ƒ์  ์˜์˜๊ฐ€ ์žˆ์Œ.
    • cobalamin โ†“, folate โ†‘ ์ด๋ฉด EPI & SIBO
  • ๋ณดํ†ต ๋‚ด์‹œ๊ฒฝ ๊ฒ€์‚ฌ๋กœ ๋‹ค๋ฅธ ์žฅ ์งˆํ™˜์„ ๋ฐฐ์ œ โ†’ ํ˜ˆ์ค‘ cobalamin&folate ๊ฒ€์‚ฌ๋กœ SIBO ์ž ์ • ์ง„๋‹จ โ†’ ํ•ญ์ƒ์ œ ๋ฐ˜์‘์„ฑ์„ ๋ณด๊ณ  ์น˜๋ฃŒ์  ์ง„๋‹จ (Presumptively treat and observe the response)

Prognosis

  • ์ง„๋‹จ์ด ๋งž๋‹ค๋ฉด ์˜ˆํ›„๋Š” ์ข‹์Œ
โœ… Serum folate & cobalamin
Folate (Vitamin B9, ์—ฝ์‚ฐ)Cobalamin (Vitamin B12)
Decreased- ์ ๊ฒŒ ์„ญ์ทจ (Low dietary intake)
- Proximal SI damage
- ์ ๊ฒŒ ์„ญ์ทจ
- SIBO, EPI
- Distal SI damage
Increased- ๋งŽ์ด ์„ญ์ทจ (High dietary intake)
- ๋น„ํƒ€๋ฏผ ๋ณด์ถฉ
- SIBO, EPI
- ๋งŽ์ด ์„ญ์ทจ
- ๋น„ํƒ€๋ฏผ ๋ณด์ถฉ
  • ์—ฝ์‚ฐ์€ ๊ทผ์œ„์†Œ์žฅ(proximal)์—์„œ ํก์ˆ˜๋˜๊ณ , ์ฝ”๋ฐœ๋ผ๋ฏผ์€ ์›์œ„์†Œ์žฅ(distal)์—์„œ ํก์ˆ˜๋จ.
    • Folate๋งŒ ๊ฐ์†Œํ•˜๋ฉด Proximal SI์˜ ๋ฌธ์ œ
    • Cobalamin๋งŒ ๊ฐ์†Œํ•˜๋ฉด Distal SI์˜ ๋ฌธ์ œ
  • SIBO, EPI โ†’ Folate ์ฆ๊ฐ€ & Cobalamin ๊ฐ์†Œ
    • SIBO : ๊ทผ์œ„์†Œ์žฅ์˜ ๋‹ค์–‘ํ•œ ์„ธ๊ท ์ด ์ฆ์‹ํ•œ ๊ฒฐ๊ณผ,
      • ๋‹ค๋Ÿ‰์œผ๋กœ ์ฆ์‹ํ•œ ์„ธ๊ท ์ด cobalamin์— bindingํ•˜์—ฌ ์›์œ„์†Œ์žฅ์—์„œ ํก์ˆ˜๋˜์ง€ ๋ชปํ•จ โ†’ Decreased cobalamin
      • ์„ธ๊ท ์ด folate๋ฅผ ํ•ฉ์„ฑํ•จ โ†’ Increased folate
    • EPI : SIBO๋ฅผ ์œ ๋ฐœํ•  ์ˆ˜ ์žˆ๋Š” ์ ์„ ์ œ์™ธํ•˜๊ณ , ๋‹จ๋…์œผ๋กœ๋„
      • ๋ถ„์ž๋Ÿ‰์ด ํฐ ์ฝ”๋ฐœ๋ผ๋ฏผ์„ ์žฅ ์ƒํ”ผ์„ธํฌ๋กœ ํก์ˆ˜๋  ์ˆ˜ ์žˆ๊ฒŒ ํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ(=IF, pancreatic intrinsic factor)์ด ๋ถ„๋น„๋˜์ง€ ์•Š์Œ โ†’ Cobalamin์ด ํก์ˆ˜๋˜์ง€ ๋ชปํ•จ
      • Cobalamin deficiency๋Š” ๊ฐœ์™€ ๊ณ ์–‘์ด ๋‘˜ ๋‹ค ๋‚˜ํƒ€๋‚˜์ง€๋งŒ, ๊ณ ์–‘์ด์—์„œ ๋” severe (๊ฐœ๋Š” ์ทŒ์žฅ&์œ„์—์„œ IF ์ƒ์‚ฐ, ๊ณ ์–‘์ด๋Š” ์ทŒ์žฅ์—์„œ๋งŒ IF ์ƒ์‚ฐ)
    • EPI ์น˜๋ฃŒ์—์„œ cobalamin ๊ต์ •๋„ ํ•จ๊ป˜ ํ•ด์ค˜์•ผ ํ•จ.

Treatment

  • Antibiotics (๋ณดํ†ต ๊ฒฝ๊ตฌ ํ•ญ์ƒ์ œ)
  • high-quality, highly digestible elimination diet (์†Œํ™”๊ฐ€ ์ž˜ ๋˜๋Š” ์ œํ•œ ์‹์ด)
  • IBD ๋“ฑ ๊ธฐ์ € ์งˆํ™˜์ด ํ•จ๊ป˜ ์žˆ์œผ๋ฉด ํ•ญ์ƒ์ œ๋ฅผ ๋Š์—ˆ์„ ๋•Œ ์žฌ๋ฐœํ•˜๊ธฐ๋„ ํ•จ, ์†Œ๋Ÿ‰์˜ ํ•ญ์ƒ์ œ๋ฅผ ์ˆ˜ ์ฃผ๊ฐ„ ํˆฌ์•ฝํ•ด์•ผ ํ•  ์ˆ˜๋„ ์žˆ์Œ.
  • Cobalamin supplementation
    • Parenteral (๊ฒฝ๊ตฌ ํˆฌ์•ฝ์œผ๋กœ๋Š” ํšจ๊ณผ ์ €์กฐ)
    • Cobalamin 400mcg/dog, IM/SC
      • 7์ผ ๋‹จ์œ„๋กœ 6์ฃผ ํˆฌ์•ฝ โ†’ 14์ผ ๋‹จ์œ„๋กœ 6์ฃผ ํˆฌ์•ฝ (3ํšŒ) โ†’ ํ•œ ๋‹ฌ ํ›„ 1ํšŒ ๋” ํˆฌ์•ฝ โ†’ ํ•œ ๋‹ฌ ํ›„ ๋†๋„ ์ธก์ •ํ•˜์—ฌ ๋‹จ์•ฝ or ์ถ”๊ฐ€ ํˆฌ์•ฝ

3.6 Small intestinal IBD

  • Inflammatory Bowel Disease (IBD, ์—ผ์ฆ์„ฑ ์žฅ์งˆํ™˜)
  • ์†Œ์žฅ์„ฑ๊ณผ ๋Œ€์žฅ์„ฑ ๊ตฌ๋ถ„, ์†Œ์žฅ์„ฑ์ด ์ผ๋ฐ˜์ 
  • ๊ทธ๋ƒฅ ์žฅ์—ผ์ด์ง€๋งŒ ์ž„์ƒ์ ์œผ๋กœ ์ค‘์š”ํ•จ

Etiology

  • Idiopathic intestinal inflammation
  • Inappropriate immune response (๋ถ€์ ์ ˆํ•œ ๋ฉด์—ญ ๋ฐ˜์‘) : ์‹์ด์— ๋Œ€ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์ด ๊ณ„์†๋˜์–ด ์—ผ์ฆ ๋ฐœ์ƒ, ์„ธ๊ท  ๊ณผ์ฆ์‹์— ์˜ํ•œ ๋ฉด์—ญ ๋ฐ˜์‘์ด ์ง€์†๋˜์–ด ์žฅ์—ผ ๋ฐœ์ƒ ๋“ฑ ๋ณตํ•ฉ์ ์ธ ์›์ธ์„ ํฌํ•จ

Clinical Features

  • (1) Lymphocytic-Plamacytic Enteritis (LPE) : ๋น„ํŠน์ด์ ์ธ ์—ผ์ฆ ์งˆํ™˜
    • ๋งŒ์„ฑ์ ์ธ ์†Œ์žฅ์„ฑ ์„ค์‚ฌ
    • ์ฒด์ค‘์ด ๊ฐ์†Œํ•˜๊ณ  ๊ตฌํ† ํ•จ
    • IBD์— ์˜ํ•ด PLE๊ฐ€ ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ (์ง„๋‹จ๋ช…์ด ์•„๋‹Œ ํ•˜๋‚˜์˜ ์ฆ์ƒ, ๊ธฐ์ € ์งˆํ™˜์„ ์ฐพ์•„์•ผ)
    • R/O : alimentary lymphoma
      • lymphocyte๋Š” round cell
      • ๋ณดํ†ต lymphoblastic lymphoma๋Š” B cell ์œ ๋ž˜์ธ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์•„ ์„ธํฌ๊ฐ€ ํผ.
      • ๊ณ ์–‘์ด์—์„œ ์ž˜ ๋ฐœ์ƒํ•˜๋Š” small cell lymphoma๋Š” small T cell ์œ ๋ž˜๋กœ, ๋ถ„ํ™”๊ฐ€ ์ž˜ ๋˜์–ด ์žˆ์–ด์„œ ๊ฑฐ์˜ ์ •์ƒ์— ๊ฐ€๊นŒ์šด lymphocyte, ๊ตฌ๋ถ„์ด ์–ด๋ ค์›€. ๋ฉด์—ญ๊ฒ€์‚ฌ๋กœ ์ข…์–‘ํ‘œ์ง€์ž๋ฅผ ํ™•์ธํ•ด์•ผ ์ง„๋‹จ ๊ฐ€๋Šฅ.
      • ์†Œ์„ธํฌ์„ฑ ๋ฆผํฌ๋งˆ์™€ ๊ฐ๋ณ„ ์–ด๋ ค์›€
  • (2) Eosinophilic Gastro Enterocolitis (EGE) : ์†Œ์žฅ์—๋„, ๋Œ€์žฅ์—๋„ ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ
    • LPE์— ๋น„ํ•ด ๋“œ๋ฌพ
    • ๋‹จ๋ฐฑ์งˆ์›์— ์˜ํ•œ ์•Œ๋Ÿฌ์ง€ ๋ฐ˜์‘์ผ ๋•Œ๊ฐ€ ๋งŽ์Œ (beef, milk)
    • ๋ฉด์—ญ์–ต์ œ์ œ๋ฅผ ์“ฐ๋ฉด ๋Œ€๋ถ€๋ถ„ ๋ฐ˜์‘์ด ์ข‹์ง€๋งŒ,
      • Feline hypereosinophilic syndrome (HES, ํ˜ธ์‚ฐ๊ตฌ๊ฐ€ ์˜จ๋ชธ์— ์นจ์œค๋˜๋Š” ์ฆํ›„๊ตฐ)์ด ์ƒ๊ธฐ๋ฉด ์˜ˆํ›„๊ฐ€ ์•ˆ ์ข‹์Œ
        • ์ผ์ข…์˜ ์ข…์–‘์„ฑ ๋ณ‘๋ณ€, ์›๋ž˜๋Š” ๊ณจ์ˆ˜ ๊ฒ€์‚ฌ๋ฅผ ํ•ด์„œ ์ „๊ตฌ์„ธํฌ ๋งŽ์ด ์ฆ์‹ํ•˜๊ณ  ํ˜ธ์‚ฐ๊ตฌ๊ฐ€ ์ •์ƒ๋ณด๋‹ค 5-10๋ฐฐ ๋†’์€ ๊ฒƒ์„ ํ™•์ธ
        • ์น˜๋ฃŒ์  ์ง„๋‹จ์ด ์œ ์šฉ โ†’ ์žฅ์—ผ์— ์ค€ํ•˜๋Š” ์Šคํ…Œ๋กœ์ด๋“œ&์‹์ด๊ด€๋ฆฌ๋ฅผ ํ•ด๋„ ๋ฐ˜์‘์ด ์—†๊ณ  ๊ณ„์† ๋‚˜๋น ์ง
        • ๊ฐœ์—์„œ๋Š” ์—†์œผ๋ฏ€๋กœ, ํ˜ธ์‚ฐ๊ตฌ ์นจ์œค์„ฑ ์žฅ์—ผ์ด์–ด๋„ ๊ด€๋ฆฌ๊ฐ€ ์ž˜๋จ (?)

Diagnosis (LPE)

  • ์ง„๋‹จ์  ๊ฐ€์น˜๊ฐ€ ๋–จ์–ด์ง. ํ™•์ง„ ์–ด๋ ค์›€.

  • Exclusion DDx + Histopathology : ์„ค์‚ฌ์˜ ๋‹ค๋ฅธ ์›์ธ์„ ๋‹ค ๋ฐฐ์ œํ•œ ์ƒํƒœ์—์„œ ์กฐ์ง ๊ฒ€์‚ฌ๋ฅผ ํ–ˆ๋Š”๋ฐ LPE ์†Œ๊ฒฌ์ด ๋‚˜์˜ค๋ฉด ์ง„๋‹จ ๊ฐ€๋Šฅ.

  • First, ์„ค์‚ฌ์˜ ์›์ธ์„ ๋ฐฐ์ œ

    • ์Œ์‹ ๋ฐ˜์‘์„ฑ(โ†’ elimination diet), ํ•ญ์ƒ์ œ ๋ฐ˜์‘, ๊ธฐ์ƒ์ถฉ(โ†’ ๊ตฌ์ถฉ), ์ข…์–‘ ๊ฐ๋ณ„
  • Second, Histopathology

    • Mucosal inflammatory infiltrates (์ ๋ง‰์˜ ์—ผ์ฆ์„ธํฌ ์นจ์œค; lymphocyte, plasmacytes)
    • Architectural changes (villus atropy, crypt changes)
    • Epithelial changes (์ ๋ง‰ ์ƒํ”ผ์„ธํฌ ๋ณ€์„ฑ)
  • ๊ณ ์–‘์ด๋Š” well-differenciated(๋ถ„ํ™”๊ฐ€ ์ž˜๋˜๋Š”) small cell lymphocytic lymphoma ์™€ ๊ฐ๋ณ„์ด ์–ด๋ ค์›€.

    • ๋ฉด์—ญํ™”ํ•™๊ฒ€์‚ฌ(์ข…์–‘์„ธํฌ์—์„œ๋งŒ ๋ฐœํ˜„๋˜๋Š” ๊ฒ€์‚ฌ)๋ฅผ ๋”ฐ๋กœ ํ•ด์•ผํ•จ.

Diagnosis (EGE)

  • ๊ฐœ์—์„œ๋Š” eosinophilia ๋‚˜ํƒ€๋‚˜๊ธฐ๋„, ์•ˆ ๋‚˜ํƒ€๋‚˜๊ธฐ๋„.
    • ํ˜ธํก๊ธฐ/ํ”ผ๋ถ€์˜ ํ˜ธ์‚ฐ๊ตฌ ์นจ์œค
    • German Sheperds ์—์„œ ํ˜ธ์‚ฐ๊ตฌ์„ฑ ์žฅ์—ผ โ†‘
  • ๊ณ ์–‘์ด์—์„œ ์—ผ์ฆ์„ฑ ์žฅ์งˆํ™˜์ธ๋ฐ ํ˜ธ์‚ฐ๊ตฌ์ฆ๊ฐ€์ฆ์ด ์žˆ๋‹ค๋ฉด EGE ๊ฐ€๋Šฅ์„ฑ ๋†’์Œ.
    • ํ˜ˆ์ค‘ eosiophil ๋†’์•„์ง€๋Š”๊ฒŒ ์ผ๋ฐ˜์ 
    • splenic, hepatic, lymph node, bone marrow ๋“ฑ ๊ด€๊ณ„์—†์–ด๋ณด์ด๋Š” ๋ถ€๋ถ„์— infiltrates..
    • ์น˜๋ฃŒ๋ฅผ ํ•ด๋ณด๊ณ , ๋ฐ˜์‘์ด ์—†์œผ๋ฉด HES๋กœ ์ง„๋‹จ

Treatment

Canine LPE<
Elimination diets
+ Antimicrobials
- ๋ณดํ†ต ๊ฒฝ๋ฏธํ•จ. ์žฅ์„ธํฌ ์†์ƒ์ด ์‹ฌํ•˜์ง€ ์•Š์€ ์ดˆ๊ธฐ์—๋Š” ์น˜๋ฃŒ ์ˆ˜์›”.
- EGE๋ฟ ์•„๋‹ˆ๋ผ LPE๋„ ์‹์ด์— ์˜ํ•ด ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ.
- ์ผ๋‹จ ์‹์ด+ํ•ญ์ƒ์ œ๊ฐ€ first.
Corticosteroid therapy
(PDS 2.2mg/kg/day PO)
- Moderate โ†’ ์ถ”๊ฐ€์ ์œผ๋กœ ๋ฉด์—ญ์–ต์ œ์ œ ์‚ฌ์šฉ
- Steroid : 1mg/kg ์ดํ•˜๋กœ ์“ฐ๋ฉด ํ•ญ์—ผ์ฆ ๋ฐ˜์‘, ๋งŽ์ด ์“ฐ๋ฉด ๋ฉด์—ญ์–ต์ œ ๋ฐ˜์‘
Immunosuppressives- Steroid ์˜ค๋ž˜ ์จ์„œ ๋ถ€์ž‘์šฉ ์šฐ๋ ค or ์ฟ ์‹ฑ ๋“ฑ ์Šคํ…Œ๋กœ์ด๋“œ ๋ถˆ๊ฐ€๋Šฅํ•œ ํ™˜์ž์—์„œ๋Š”..
- budesonide (PDS sparing drugs)
: ์ „์‹  ์—ผ์ฆ ์ค„์ด๋Š” PDS์™€ ๋‹ฌ๋ฆฌ budesonide๋Š” ์žฅ์—๋งŒ ๊ตญ์†Œ์ ์œผ๋กœ ์ž‘์šฉํ•˜๋Š” ์Šคํ…Œ๋กœ์ด๋“œ. ๋ถ€์ž‘์šฉ์ด ํ›จ์”ฌ ์ž‘์Œ.
- Azathioprine : ์˜ค๋ž˜ ์“ฐ๋ฉด ๊ณจ์ˆ˜์–ต์••, ๊ฐ„๋…์„ฑ / ๊ณ ์–‘์ด๋Š” ๋Œ€์‚ฌ๊ฐ€ ๋นจ๋ผ ๋ถˆ๊ฐ€.
- Chlorambucil : ํ•ญ์•”์ œ(=๊ฐ•๋ ฅํ•œ ๋ฉด์—ญ์–ต์ œ์ œ). ๊ณ ์–‘์ด์—์„œ Azathioprine ๋Œ€์‹  ์”€.
- Cyclosporine
Cobalamin therapy- Cobalamin(VB12) : ์žฅ์„ธํฌ์˜ ์žฌ์ƒ๊ณผ ํšŒ๋ณต์„ ๋„์›€.
*์ ์ ˆํ•œ ์น˜๋ฃŒ ์‹คํŒจ?- ์ž˜๋ชป๋œ ์น˜๋ฃŒ ๋ฐฉํ–ฅ
- ๋ณดํ˜ธ์ž๊ฐ€ ์•ฝ์„ ์ž˜ ์•ˆ ๋จน์ผ ์ˆ˜ ์žˆ์Œ์„ ์˜์‹ฌ (โ†’ ๋ฐ˜์‘ ์•ˆ ๋‚˜ํƒ€๋‚œ๋‹ค๊ณ  ๋ฐ”๋กœ ์šฉ๋Ÿ‰ ์˜ฌ๋ฆฌ๊ธฐ๋ณด๋‹จ..)
- Misdiagnosis : lymphoma๋ฅผ ์˜ค์ง„ํ–ˆ์„ ์ˆ˜ ์žˆ์Œ
Feline LPE<
Elimination diet + Metronidazole๊ธฐ๋ณธ์ ์œผ๋กœ ์ด๋ ‡๊ฒŒ ์‹œ์ž‘
Steroid - ์ดˆ๊ธฐ๋ถ€ํ„ฐ ๊ณ ์šฉ๋Ÿ‰- Steroid๊ฐ€ potency๊ฐ€ ์ข‹์•„์„œ, ์ผ๋‹จ ์ดˆ๊ธฐ์— ์žก์Œ.
- ๋‹น๋‡จ ๋“ฑ ์“ธ ์ˆ˜ ์—†์œผ๋ฉด budesonide ๊ฐ€๋Šฅ
Chlorambucil (ํ•ญ์•”์ œ)- Severe LPE๋‚˜ ๊ณ ์–‘์ด์˜ small cell lymphoma ๋‘˜ ๋‹ค ์ ์šฉ ๊ฐ€๋Šฅ
- ์ง„๋‹จ์ด ์–ด๋ ค์šธ ๋•Œ ๋งŽ์ด ์”€
Cobalamin therapy,
Nutritional supplementation
- parenterally : ์ด๋Ÿฐ ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์ง€๋Š” ์•Š์Œ
Canine EGE<
Strict elimination diet- EGE๋Š” ํ™•์‹คํ•˜๊ฒŒ ์ œํ•œ ์‹์ด. ์ตœ์†Œ 8์ฃผ ๋™์•ˆ ๋ฌผ๊ณผ ์ œํ•œ ์‚ฌ๋ฃŒ๋งŒ ๊ธ‰์—ฌ.
- ๊ฐ„์‹ ์ฃผ์ง€ ๋ง๋ผ๊ณ  ๊ผญ ๊ฐ•์กฐํ•ด์•ผ ํ•จ!! (๋ฌผ๊ณผ ์‚ฌ๋ฃŒ ์™ธ์— ๋“ค์–ด๊ฐ€๋ฉด X)
- ์ œํ•œ์‚ฌ๋ฃŒ ์™ธ์˜ ๊ฒƒ์„ ๋จน์œผ๋ฉด ๋‹ค์‹œ 0์ผ๋ถ€ํ„ฐ ์‹œ์ž‘
- ์‹ฌ์žฅ์‚ฌ์ƒ์ถฉ์•ฝ(ํ•˜ํŠธ๊ฐ€๋“œ)๋„ ๊ธˆ์ง€!! (๋ฐ”๋ฅด๋Š” ์•ฝ์œผ๋กœ ๋ณ€๊ฒฝ)
Corticosteroid therapy
์žฌ๋ฐœํ•œ๋‹ค๋ฉด,- ์‚ฌ๋ฃŒ๋ฅผ 2์ฃผ ๊ฐ„๊ฒฉ์œผ๋กœ ๋ฐ”๊ฟ”์„œ back and forth๋กœ ๊ธ‰์—ฌ
Feline EGEHES๊ฐ€ ์žˆ๋Š”์ง€ ์—†๋Š”์ง€๊ฐ€ ์ค‘์š”
Steroid therapy์Šคํ…Œ๋กœ์ด๋“œ ์น˜๋ฃŒ๋Š” ๋˜‘๊ฐ™์ง€๋งŒ, HES๊ฐ€ ์žˆ์œผ๋ฉด ๋ฐ˜์‘์ด ์—†๋‹ค.
Steroid Tapering- IBD๋Š” ๋งŒ์„ฑ์ , ๋ชธ์ด ์ธ์ง€ํ•˜์ง€ ๋ชปํ•˜๊ฒŒ ์„œ์„œํžˆ.
- Steroid + Aza, cyclo ๋“ฑ๊ณผ ๋ณ‘์šฉํ•  ๋•Œ๊ฐ€ ๋งŽ์€๋ฐ,
- ์ตœ์†Œ 2-4์ฃผ๋Š” ์•ฝ์„ ์ค„์ด์ง€ ์•Š์•„์•ผ.
- ํ•œ ๋ฒˆ์— ํ•œ ๊ฐœ์”ฉ๋งŒ ๊ฐ๋Ÿ‰ (๋ฐ˜์‘์„ฑ ํ™•์ธ)
- 2-3์ฃผ์— 1๋ฒˆ ๊ฐ๋Ÿ‰, 1๊ฐœ ์ด์ƒ ๊ฐ๋Ÿ‰ํ•˜์ง€ ์•Š์Œ
- ์‚ฌ๋ฃŒ ๊ด€๋ฆฌ, ํ•ญ์ƒ์ œ ๊ด€๋ฆฌ๋Š” ๊ณ„์† ์ง€์† (๊ฐ๋Ÿ‰ํ•˜๋ฉด์„œ ์žฌ๋ฐœ ์ง„์งœ ๋งŽ์Œ)

Prognosis

  • ์ž˜ ๊ด€๋ฆฌํ•˜๋ฉด ์˜ˆํ›„๋Š” ์ข‹์€ ํŽธ
  • Poor sings
    • Severe ์งˆํ™˜์ด ๋งŽ์ด ์ง„ํ–‰๋˜์–ด severe hypoalbuminemia
    • Poor body condition score
  • ํ‰์ƒ ์‹์ด ๊ด€๋ฆฌ ํ•ด์ค˜์•ผ ํ•จ
  • ์ž˜ ์ฃฝ์ง€๋Š” ์•Š์ง€๋งŒ, ์•ฝ๋ฌผ์€ ๊ณ„์† ์‚ฌ์šฉ. ์ฆ์ƒ์€ ์žกํžˆ์ง€๋งŒ ๊ณ„์† ๊ด€๋ฆฌํ•ด์•ผ ํ•œ๋‹ค๋Š” ๊ฒƒ ๊ฐ•์กฐ
    • Iatrogenic Cushing syndrome (์˜์ธ์„ฑ ์ฟ ์‹ฑ) ์กฐ์‹ฌ

3.7 Large intestinal IBD

Etiology

  • = Canine lymphocytic-plasmacytic colitis (LPC)
  • ๋Œ€์žฅ์„ฑ ์„ค์‚ฌ (์—ฐ๋ณ€, mucus ๋ฌป์„ ์ˆ˜ ์žˆ์Œ, ์‚ด์ด ๋งŽ์ด ๋น ์ง€์ง€ ์•Š์Œ, ๋ƒ„์ƒˆ ๋œ ๋‚จ)

Clinical Features

  • Canine
    • ๊ฐœ๋Š” ์†Œ์žฅ or ๋Œ€์žฅ ํ•˜๋‚˜๋งŒ ๊ฐ€์งˆ ๋•Œ๊ฐ€ ๋งŽ๊ณ ,
    • ์—ฐ๋ณ€(soft stool) ์™ธ์˜ ์ฆ์ƒ์€ ์ž˜ ์—†์Œ
  • Feline
    • Hematochezia : ํ˜ˆ๋ณ€์ด ๋” ์ž˜ ์ƒ๊น€
    • Diarrhea : ์†Œ์žฅ+๋Œ€์žฅ IBD ํ•จ๊ป˜ ๋ฐœ์ƒํ•˜๊ธฐ ์‰ฌ์›€.
      • Concurrent with LPE

Diagnosis

  • ์†Œ์žฅ์„ฑ IBD์™€ ์œ ์‚ฌ
  • ํ˜ˆ๋ณ€์˜ ๋‹ค๋ฅธ ์›์ธ ๋ฐฐ์ œํ•˜๊ณ , ์กฐ์ง ๊ฒ€์‚ฌ.

Treatment

  • ๊ณ ์„ฌ์œ ์„ฑ ์‹์ด, hypoallergenic diets
    • ์„ฌ์œ ์งˆ์€ ๊ฑฐ์น ๊ธฐ ๋•Œ๋ฌธ์—, ์†Œํ™”๊ฐ€ ์–ด๋ ต๊ณ  ๊ณ„์† ์ž๊ทน์„ ์คŒ.
  • Corticosteroids +/- metronidazole
  • sulfasalazine : colitis (๊ฒฐ์žฅ์— ํŠน์ด์ ์œผ๋กœ ์ž‘์šฉํ•ด์„œ ์—ผ์ฆ ์ค„์—ฌ์คŒ), salicilic acid๊ฐ€ ๋‚˜์˜ค๋ฏ€๋กœ ๊ณ ์–‘์ด์—์„œ๋Š” ์‚ฌ์šฉ ์ฃผ์˜.

Sulfasalazine์˜ complain

  • ๊ฑด์„ฑ ๊ฐ๊ฒฐ๋ง‰์—ผ์ด ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ.
  • ๋ง›์ด ์—†์–ด์„œ ๋ฑ‰์–ด๋‚ด๋ ค๊ณ  ํ•ด์„œ, ์นจ์ด ์ž… ์ฃผ๋ณ€์— ๊ณ ์ด๋ฉด์„œ ์ฃผํ™ฉ์ƒ‰์œผ๋กœ ์—ผ์ƒ‰๋  ์ˆ˜ ์žˆ์ง€๋งŒ ํ„ธ๊ฐˆ์ด ๋•Œ ์‚ฌ๋ผ์ง

Prognosis

ํ˜ˆ๋ณ€ ๋•Œ๋ฌธ์— ์†Œ์žฅ์„ฑ IBD๋ณด๋‹ค ์œ„ํ—˜ํ•ด ๋ณด์ด์ง€๋งŒ, ์˜ˆํ›„๋Š” better.

3.8 Granulomatous enteritis, gastritis

Etiology

  • ๊ฐœ์™€ ๊ณ ์–‘์ด ๋‘˜ ๋‹ค์—์„œ Rare type of IBD
  • Granulomatous IBD๊ฐ€ ์‚ฌ๋žŒ์˜ Crohnโ€™s Dz (ํฌ๋ก ๋ณ‘)๊ณผ ์œ ์‚ฌ.

Clinical features

  • ์•ฝ๋ฌผ ์น˜๋ฃŒ์— ๋ฐ˜์‘์ด ๋ณ„๋กœ ์—†์Œ
  • ๊ตญ์†Œ์ ์œผ๋กœ ๋ฐœ์ƒํ•˜๋ฉด ์ ˆ์ œํ•ด์•ผ ํ•  ์ˆ˜๋„ ์žˆ์Œ
  • PLE์™€ ๋น„์Šทํ•œ ์ž„์ƒ ์ฆ์ƒ
  • ์ฒด์ค‘ ๊ฐ์†Œ, ์„ค์‚ฌ

Diagnosis

  • ์กฐ์ง ๊ฒ€์‚ฌ๋กœ ์ง„๋‹จ (macrophagy๊ฐ€ ๋งŽ์Œ)

Treatment

  • ๊ตญ์†Œ์ ์ด๋ฉด ์ˆ˜์ˆ ์  ์ ˆ์ œ
  • Diffuseํ•˜๋‹ค๋ฉด ์˜ˆํ›„ ๋งค์šฐ poor, ๋ชจ๋“  ์ˆ˜๋‹จ์„ ๋™์›ํ•ด๋ณด์ž.
    • Corticosteroids
    • Azathioprine
    • Metronidazole
    • Dietary therapy

Prognosis

  • rareํ•˜์ง€๋งŒ, ์˜ˆํ›„๋Š” poor

3.9 Intestinal lymphangiectasia (๋ฆผํ”„๊ด€ํ™•์žฅ์ฆ)

Etiology

  • ์žฅ์— ๋ฐœ์ƒํ•˜๋Š” ๋ฆผํ”„๊ด€ํ™•์žฅ์ฆ

๋ฆผํ”„์•ก์˜ ํ๋ฆ„

  • ์žฅ์— ์žˆ๋Š” ์œ ๋ฏธ๊ด€
  • ์ง€๋ฐฉ์ด ๋„ˆ๋ฌด ์ปค์„œ ๋ฐ”๋กœ ์žฅ์ ๋ง‰์œผ๋กœ ํก์ˆ˜ ๋ถˆ๊ฐ€
  • ์œ ๋ฏธ๊ฐ€ ํฌํ•ฉํ•ด์„œ ์œ ๋ฏธ๊ด€์œผ๋กœ ๊ฐ€์ ธ๊ฐ€๋ฉด โ†’ ๋ฆผํ”„๊ด€์œผ๋กœ ๊ฐ€์ ธ๊ฐ€์„œ โ†’ thoracic duct โ†’ ์ •๋งฅ
  • ๋ฆผํ”„๊ด€ ์–ด๋”˜๊ฐ€๊ฐ€ ๋ง‰ํ˜€์„œ ์••๋ ฅ์ด ๋ฐœ์ƒํ•˜๋ฉด โ†’ lacteal์ด ํ™•์žฅ๋จ
  • ์›์ธ

    • ๋ฆผํ”„๊ด€์„ ๋ง‰๋Š” ๋ชจ๋“  ๊ฒƒ์— ์˜ํ•ด ์ƒ๊ธธ ์ˆ˜ ์žˆ์Œ.
    • ๋ฆผํ”„๊ด€์€ ๋งˆ์ง€๋ง‰์— ์ •๋งฅ์œผ๋กœ ๋น ์ง€๊ธฐ ๋•Œ๋ฌธ์—, ์ •๋งฅ ๊ณ ํ˜ˆ์••์ผ ๋•Œ๋„ ๋ฐœ์ƒ ๊ฐ€๋Šฅ
      • ์šฐ์‹ฌ๋ถ€์ „์— ์˜ํ•ด ์ •๋งฅ ๊ณ ํ˜ˆ์•• ๋ฐœ์ƒ ๊ฐ€๋Šฅ
      • Cranial caudal vena cava์— ์••๋ ฅ โ†’ ๊ฐ„ ๋“ฑ ๋ณต์ˆ˜ ๋ฐœ์ƒ
  • ๋ฆผํ”„๊ด€ ํ๋ฆ„์ด ๋” ๋ง‰ํžˆ๋ฉด์„œ ์ ์  ๋” ์‹ฌํ•ด์ง

    • ์ข…์–‘์— ์˜ํ•ด ๋ˆŒ๋ฆด ์ˆ˜๋„ ์žˆ์Œ
  • ๋ง‰ํ˜€์„œ ๋น ์ ธ๋‚˜๊ฐ€์ง€ ๋ชปํ•˜๋ฉด์„œ ํŒŒ์—ด โ†’ ๋ฆผํ”„์•ก ๋ˆ„์ถœ (protein, lymphocytes, chylomicrons๊ฐ€ ๋งŽ์Œ) โ†’ ์˜ค๋žซ๋™์•ˆ ์žฅ๊ฐ„๋ง‰์— ๋‚จ์•„์„œ ์ด๋ฌผ๋กœ ์ž‘์šฉ, ๋งŒ์„ฑ์ ์œผ๋กœ ์—ผ์ฆ ๋ฐ˜์‘์ด ์ƒ๊น€, macrophage๊ฐ€ ์™€์„œ ์žก์•„๋จน์Œ โ†’ ์žฅ๊ฐ„๋ง‰์— **์ง€์งˆ์œก์•„์ข…(lipogranuloma)**์ด ์ƒ๊น€

  • ๋ถ„์ ˆ์„ฑ โ†’ jejunum์—์„œ๋งŒ or ileum์—์„œ๋งŒ ๋ณด์ผ ๋•Œ๊ฐ€ ๋งŽ์Œ.

  • Gastroscopy๋Š” ์‹ญ์ด์ง€์žฅ๊นŒ์ง€๋งŒ ๊ฐ€๋Šฅ, ๊ณต์žฅ์ด๋‚˜ ํšŒ์žฅ์— ์ƒ๊ธด ๊ฒƒ ๊ฐ™์œผ๋ฉด ๋‚ด์‹œ๊ฒฝ(colonoscopy)์œผ๋กœ ๋’ค์—์„œ ํ™•์ธํ•ด์•ผ.

  • ๊ณต์žฅ, ํšŒ์žฅ ์ชฝ ๋ฌธ์ œ๋กœ ์˜์‹ฌ๋˜๋ฉด ์ฐจ๋ผ๋ฆฌ ์ˆ˜์ˆ  โ†’ ์ „์ธต biopsyํ•˜๋Š” ๊ฒŒ ์ข‹์Œ

Clinical Features

  • Higher risk : ์š”ํฌ์…”ํ…Œ๋ฆฌ์–ด ๋“ฑ

  • ์„ค์‚ฌ (์ผ๋ฐ˜์ ์ด์ง€ ์•Š์Œ)

  • Transudative ascites (์žฅ๊ธฐ์ ์œผ๋กœ ๋ณต์ˆ˜ ๋ฐœ์ƒ)

  • (์ˆ˜์ˆ  ์‹œ) intestinal lipogranulomas

  • lymphangiectasia โ†’ protein, lymph, cholesterol์ด ๋–จ์–ด์ง

  • ์‘๊ณ ์ธ์ž๊ฐ€ ๋„ˆ๋ฌด ๋–จ์–ด์ง€๋ฉด thromboembolism, DIC

Diagnosis

  • ์„ธ ๊ฐœ๊ฐ€ ์ œ์ผ ์ค‘์š”! (์•Œ๋ถ€๋ฏผ, ์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๋ฆผํ”„ ๊ฐ์†Œ)

    • Hypoalbuminemia
    • Hypocholesterolemia
    • Lymphopenia
  • U/S : Hyperechoic mucosal striations

    • lacteal์ด ๋ณด์—ฌ์„œ ์ค„์ด ๊ด€์ฐฐ๋จ (์žฅ์˜ layer์— ์ˆ˜์งํ•œ ์ผ์ž ์„ )
    • ์ž˜ ์ƒ๊ธฐ์ง„ ์•Š์ง€๋งŒ ์ƒ๊ธฐ๋ฉด ๊ฐ•๋ ฅํ•˜๊ฒŒ ์˜์‹ฌ
  • ์กฐ์ง ๊ฒ€์‚ฌ : Dilated lacteals

  • ๋‚ด์‹œ๊ฒฝ : ์ข…์ข… ์ง„๋‹จ์  ๊ฐ€์น˜ ์žˆ์Œ. (ileoscopy; ๋’ค๋กœ ํšŒ์žฅ๊นŒ์ง€ ํ™•์ธํ•ด์•ผ ํ•˜๊ธฐ ๋•Œ๋ฌธ)

    • lacteal์ด ๋ฆผํ”„์•ก์„ ๋จธ๊ธˆ์€ ์ฑ„๋กœ dilation๋˜์–ด ์žˆ์Œ. ์ ๋ง‰์— ์ข์Œ€์ด ๋ฐ•ํžŒ ๋“ฏํ•œ ์†Œ๊ฒฌ.
    • ๊ธฐ๋ฆ„์ง„ ์Œ์‹์œผ๋กœ ๋งˆ์ง€๋ง‰ ์‹์‚ฌ โ†’ ๋” ๋ˆˆ์— ์ž˜ ๋ณด์ž„
  • ์•Œ๋ถ€๋ฏผ์ด ์‹ฌํ•˜๊ฒŒ ๋‚ฎ์€ ํ™˜์ž์—์„œ ์ „์ธต ๊ฒ€์‚ฌ(Full-thickness surgical biopsies)

    • but ์•Œ๋ถ€๋ฏผ์ด ๋‚ฎ์œผ๋ฉด ํ๋ณต์ด ์ž˜ ์•ˆ ๋˜๋ฏ€๋กœ ์กฐ์‹ฌ!

Treatment

  • Ultra-low-fat diet (์ด์ €์ง€๋ฐฉ์‚ฌ๋ฃŒ)
    • ๋ฆผํ”„์•ก์„ ์ค„์—ฌ์ฃผ๋ฉด ๋ฌธ์ œ๊ฐ€ ๋œ ์ƒ๊น€.
    • ์žฅ์‡„์ง€๋ฐฉ์‚ฐ์„ ์ค„์—ฌ์คŒ
    • ์ค‘์‡„์ง€๋ฐฉ์‚ฐ์œผ๋กœ ์กฐ๊ธˆ ๋ณด์ถฉํ•ด์ฃผ๋ฉด ์ข‹์Œ (์ฝ”์ฝ”๋„› ์˜ค์ผ ๋“ฑ)

์žฅ์‡„์ง€๋ฐฉ์‚ฐ, ๋‹จ์‡„์ง€๋ฐฉ์‚ฐ, ์ค‘์‡„์ง€๋ฐฉ์‚ฐ

  • ์ง€๋ฐฉ์‚ฐ์€ ๋’ค์— ํƒ„์†Œ ๊ณ ๋ฆฌ๊ฐ€ ๋ช‡ ๊ฐœ ๋ถ™๋ƒ์— ๋”ฐ๋ผ ์žฅ/๋‹จ/์ค‘์œผ๋กœ ๋ถ„๋ฅ˜.
  • ์ค‘์‡„, ์žฅ์‡„์ง€๋ฐฉ์‚ฐ๋งŒ ์Œ์‹์œผ๋กœ ์„ญ์ทจ ๊ฐ€๋Šฅ (๋‹จ์‡„์ง€๋ฐฉ์‚ฐ์€ ๋ชธ์—์„œ ๋ฐœํšจ๋˜์–ด ์ƒ๊น€)
  • ์žฅ์‡„์ง€๋ฐฉ์‚ฐ์œผ๋กœ ๋จน์œผ๋ฉด ๋„ˆ๋ฌด ํฌ๊ณ  ์ง€๋ฐฉ์‚ฐ์ด๋ผ ํก์ˆ˜ ์–ด๋ ค์›€. Chylomicron์˜ ๊ณต์ • ๊ณผ์ •์„ ๊ฑฐ์ณ์„œ ๋ฆผํ”„๊ด€ โ†’ ์ •๋งฅ์œผ๋กœ ๋“ค์–ด๊ฐ.
  • ๋‹จ์‡„, ์ค‘์‡„๋Š” ์ˆ˜์šฉ์„ฑ โ†’ ์žฅ์„ธํฌ๊ฐ€ ๊ทธ๋Œ€๋กœ ํก์ˆ˜ ๊ฐ€๋Šฅ.
  • ๋ฆผํ”„์•ก์„ ์ค„์—ฌ์•ผ ํ•œ๋‹ค๋ฉด, ์ค‘์‡„์ง€๋ฐฉ์‚ฐ์€ ์ƒ๊ด€์—†์Œ, ์žฅ์‡„์ง€๋ฐฉ์‚ฐ๋งŒ ์ค„์—ฌ์ฃผ๋ฉด ๋จ.
  • ํ•ญ์—ผ์ฆ/๋ฉด์—ญ์–ต์ œ
    • PDS + Azathioprine + Cyclosporine ์ฒ˜์Œ๋ถ€ํ„ฐ 3๊ฐœ ์“ฐ๋Š” ๊ฒฝ์šฐ๊ฐ€ ๋งŽ์Œ
    • ๊ณ ์–‘์ด์—์„œ๋Š” ๋ฐœ๋ณ‘ ๋‚ฎ์Œ
  • serum albumin ๋ชจ๋‹ˆํ„ฐ๋ง; ์•Œ๋ถ€๋ฏผ ๋†๋„ ๋‚ฎ์„์ˆ˜๋ก ์˜ˆํ›„ ์•ˆ ์ข‹์Œ.

Prognosis

  • ์ดˆ๊ธฐ์— ์ง„๋‹จํ•˜๋ฉด ์˜ˆํ›„๊ฐ€ ์ข‹์ง€๋งŒ, ๊ทธ๋Ÿฌ๊ธฐ ์–ด๋ ค์›€ (์šฐ์—ฐํžˆ ์ง„๋‹จ๋˜๋ฉด ์ข‹์ง€๋งŒ..)
  • ์ €์ง€๋ฐฉ์‚ฌ๋ฃŒ ์ •๋„๋กœ ์™„ํ™”๋˜๋Š” ๊ฒฝ์šฐ๋„ ์žˆ์Œ
  • ๊ทธ๋Ÿผ์—๋„ ์‚ฌ๋งํ•˜๋Š” ๊ฒฝ์šฐ๋„ ์žˆ์Œ

3.10 Alimentary lymphoma (์†Œํ™”๊ธฐ ๋ฆผํ”„์ข…)

  • ์žฅ์— ์ƒ๊ธฐ๋Š” lymphoma vs. ์žฅ์ด ์•„๋‹Œ ๊ณณ์— ์ƒ๊ธฐ๋Š” lymphoma.

Etiology

  • ๋ฆผํ”„๊ตฌ์˜ ์ข…์–‘์„ฑ ๊ณผ์ฆ์‹ (neoplastic proliferation of lymphocytes)

  • FeLV : ๊ณ ์–‘์ด์—์„œ๋Š” ๋ฐ˜๋“œ์‹œ ๊ฒ€์‚ฌ, ์–‘์„ฑ์ด๋ฉด ์น˜๋ฃŒ ์˜ˆํ›„๊ฐ€ ์ข‹์ง€ ์•Š์Œ

  • LPE : lymphoma์˜ ์ „ ๋‹จ๊ณ„๋กœ์„œ lymphoma๋กœ ๋ฐœ๋‹ฌํ•  ์ˆ˜ ์žˆ๋‹ค..? (๋Š” ๋ง์ด ์žˆ์—ˆ์ง€๋งŒ,)

    • ์ฒ˜์Œ๋ถ€ํ„ฐ lymphoma์˜€๋Š”๋ฐ ์ž˜๋ชป ์ง„๋‹จ๋˜์–ด IBD๋กœ ์˜ค์ง„ํ•œ ๊ฑฐ๋ผ๋Š” ๊ฒŒ ์œ ๋ ฅ
  • ๋‘˜ ๋‹ค์—์„œ ์ƒ๊ธธ ์ˆ˜ ์žˆ์ง€๋งŒ

    • ๊ณ ์–‘์ด์—์„œ๋Š” Alimentary lymphoma, ๊ฐœ์—์„œ๋Š” Extraintestinal lymphoma๊ฐ€ ํ”ํ•จ (lymph nodes, liver, spleen)
    • lymphoblastic lymphoma (LL) : ํฐ ์„ธํฌ๊ฐ€ ๋ณด์ด๊ธฐ ๋•Œ๋ฌธ์— ์ง„๋‹จ๋„ ์‰ฝ๊ณ  ์น˜๋ฃŒ ๋ฐ˜์‘๋„ ๋น ๋ฆ„ (์ง„ํ–‰๋„ ๊ทธ๋งŒํผ ๋น ๋ฆ„)
      • B cell type (common - ์˜ˆํ›„๊ฐ€ ์ข‹์Œ), T cell type
    • Well-differentiated small cell lymphoma (SCL) : ์ฃผ๋กœ ๊ณ ์–‘์ด
    • Large granular lymphocyte lymphoma : ํฐ ๊ณผ๋ฆฝ์„ lymphocyte ์•ˆ์— ๊ฐ€์ง, ๊ณ ์–‘์ด์—์„œ ๋ฐœ์ƒํ•˜๋Š” ์•„์ฃผ ๋“œ๋ฌธ ํ˜•ํƒœ, ๋ณผ ์ผ ์—†์Œ

Clinical Features

  • Alimentary LL (dogs, cats)
    • Dramatic signs : ์ง„ํ–‰์„ฑ ์ฒด์ค‘ ๊ฐ์†Œ, ๊ธฐ๋ ฅ๋ถ€์ง„, ๊ตฌํ† , ์†Œ์žฅ์„ฑ ์„ค์‚ฌ
    • PLE
    • Mesenteric lymphadenopathy (์žฅ๊ฐ„๋ง‰ ๋ฆผํ”„์ ˆ - ๋Œ€๋ถ€๋ถ„ ๋ถ€์Œ)
  • Alimentary SCL in cats : ๋œ ๊ณต๊ฒฉ์ ์œผ๋กœ ์ง„ํ–‰, mild signs.. ๊ทธ๋ ‡๊ฒŒ ์‹ฌ๊ฐํ•œ์ง€ ๋ชจ๋ฅด๊ณ  ๋‚ด์›ํ•˜๊ธฐ ์‰ฌ์›€
    • Weight loss, vomiting, diarrhea

Diagnosis (LL)

  • FNA biopsy๋กœ ์ง„๋‹จ์ด ์‰ฌ์›€, ๋šœ๋ ทํ•œ malignant lymphocytes ์ฐพ์œผ๋ฉด ๋จ.
  • ํ˜ˆ์•ก ๊ฒ€์‚ฌ : paraneoplastic hypercalcemia
    • T์„ธํฌ ์œ ๋ž˜์˜ lymphoma์—์„œ ๋‚˜ํƒ€๋‚˜๋Š” paraneoplastic syndrome, ์˜ˆํ›„๊ฐ€ ์ข‹์ง€ ์•Š์Œ
    • PTH-rP (parathyroid hormone related peptide; ๋ถ€๊ฐ‘์ƒ์„  ํ˜ธ๋ฅด๋ชฌ์ฒ˜๋Ÿผ ์ƒ๊ธด ๋‹จ๋ฐฑ์งˆ) ๋ฅผ ๋ถ„๋น„ํ•จ, ์ด ์ˆ˜์น˜๋ฅผ ๊ฒ€์‚ฌํ•˜๊ธฐ๊ฐ€ ์–ด๋ ค์›€.. (์™ธ๊ตญ)
    • ๋Œ€์‹  Hypercalcemia ํ™•์ธ (high Ca, low PTH : rP๊ฐ€ ๋‚˜์˜ค๋ฉด PTH๋Š” ๋–จ์–ด์ง.)
      โ‡’ โ€˜PTH๋Š” ์•„์ฃผ ๋‚ฎ์œผ๋ฉด์„œ Ca์ด ๋†’์€ ์ƒํƒœโ€™ ์ด๋ฉด T cell ์œ ๋ž˜ lymphoma๋ผ๊ณ  ์ž ์ • ์ง„๋‹จ ๊ฐ€๋Šฅ
  • ์กฐ์ง ๊ฒ€์‚ฌ
    • ๋‚ด์‹œ๊ฒฝ : ๋Œ€๋ถ€๋ถ„ ๋‚ด์‹œ๊ฒฝ์œผ๋กœ ์ง„๋‹จ๋จ, ๊ฐ„ํ˜น ๋†“์น  ์ˆ˜ ์žˆ์Œ.
    • ์ˆ˜์ˆ  or ๋ณต๊ฐ•๊ฒฝ์œผ๋กœ(laparoscopically) ์ „์ธต ์กฐ์ง ๊ฒ€์‚ฌ(full-thickness tissue) : ํ™•์‹คํ•˜๊ฒŒ ํ™•์ธํ•˜๋ ค๋ฉด ์ „์ธต ๊ฒ€์‚ฌ, ๋ณดํ˜ธ์ž์—๊ฒŒ ์ž˜ ์•ˆ๋‚ด.

Diagnosis (Feline SCL)

์ง„๋‹จ์ด ์–ด๋ ค์›€.

Feline SCL
ํ˜ˆ์•ก๊ฒ€์‚ฌ- Non-regenerative anemia (50%)
- Regenerative anemia & hypoalbuminemia (50%)
- Decreased cobalamin & Folate (70%) - ๊ทธ๋‚˜๋งˆ ํŠน์ง•์ ์ด์ง€๋งŒ, SIBO์™€ ๋ณ‘๋ฐœํ•˜๋ฉด folate ์ •์ƒ์œผ๋กœ ๋‚˜์˜ฌ ์ˆ˜๋„.
- Elevated ALT, ALP
๋‚ด์‹œ๊ฒฝ
์ƒ๊ฒ€
- Endoscopic mucosal biopsies (lymphoma๊ฐ€ ์ ๋ง‰์ธต๊นŒ์ง€ ์นจ์œค๋œ ๊ฒฝ์šฐ, ์ž ์ • ์ง„๋‹จ ๊ฐ€๋Šฅ)
(IBD๋Š” ์ ๋ง‰์— ์—ผ์ฆ, SCL์€ ์ ๋ง‰ํ•˜์ธต์ด๋‚˜ ๊ทผ์œก์ธต์—์„œ ๋จผ์ € ์ƒ๊ธฐ๊ณ  ์ ๋ง‰์ธต์œผ๋กœ ์นจ์œค. ์ ๋ง‰์— ์ข…์–‘์ด ์˜ฌ๋ผ์™€ ์žˆ์œผ๋ฉด ๋‚ด์‹œ๊ฒฝ biopsy๋กœ๋„ ์ง„๋‹จ ๊ฐ€๋Šฅ(๋‚ด์‹œ๊ฒฝ์œผ๋กœ๋Š” ๋ณดํ†ต ์ ๋ง‰์ธต, ๋งŽ์ด ๋–ผ๋„ ๊ฒจ์šฐ ์ ๋ง‰ ํ•˜์ธต ์ผ๋ถ€๊นŒ์ง€). ์ดˆ๊ธฐ SCL์ด๋ฉด ์ข…์–‘์€ ์•ˆ ๋‚˜์˜ค๊ณ  ์—ผ์ฆ๋งŒ ๋‚˜์˜ฌ ์ˆ˜๋„ ์žˆ์Œ. ๊ทธ๋ž˜๋„ ๊ทธ๋‚˜๋งˆ ์ „์ธต ์กฐ์ง ๊ฒ€์‚ฌ์— ๋น„ํ•ด ๋น„์นจ์Šต์ ์ด๋ฉด์„œ ๋Œ€๋ถ€๋ถ„ ์ง„๋‹จ ๊ฐ€๋Šฅ, but ๊ฐ„ํ˜น ์˜ค์ง„.)

- Lymphocytes in the submucosa โ†’ not specific
(IBD ์—ผ์ฆ์„ธํฌ๋Š” ์ ๋ง‰์ธต์—๋งŒ ๊ตญํ•œ๋˜๋‹ˆ๊นŒ, ๋ฆผํ”„๊ตฌ๊ฐ€ ์ ๋ง‰ํ•˜์ธต์—์„œ ๋ฐœ๊ฒฌ๋˜๋ฉด ๋ฆผํ”„์ข…์ด๋‹ค? โ‡’ ์ ๋ง‰ํ•˜์ธต์—์„œ๋„ ์ •์ƒ์ ์œผ๋กœ ์—ผ์ฆ์„ธํฌ๊ฐ€ ๋ณด์ผ ์ˆ˜ ์žˆ์Œ. ์ด๊ฑธ ๋ณด๊ณ  ์ง„๋‹จํ•  ์ˆ˜ ์—†์Œ, ๊ทผ์œก์ธต ์นจ์œค์„ ๋ณด๋Š” ๊ฒŒ ํ™•์‹ค.)
- Full-thickness biopsies (๊ฐ€์žฅ ํ™•์‹ค)
์ดˆ์ŒํŒŒ๋‚ด์‹œ๊ฒฝ + ๋ณด์กฐ์ ์œผ๋กœ ์ดˆ์ŒํŒŒ๋„ ์œ ์šฉ.
- Thickening of the muscularis layer : ๊ทผ์œก์ธต์ด >3mm ๋‘๊บผ์›Œ์ ธ ์žˆ์œผ๋ฉด LL๋ณด๋‹ค SCL์ผ ๊ฐ€๋Šฅ์„ฑ์ด ๋†’์Œ.
- Mesenteric lymphadenopathy (Target lesions) : ๋ฆผํ”„๊ตฌ์˜ ์ค‘์‹ฌ๋ถ€๊ฐ€ ์ข…์–‘ ๋•Œ๋ฌธ์— ๊ดด์‚ฌ โ†’ ๊ดด์‚ฌ๋œ ๋ถ€๋ถ„์ด ์„ฌ์œ ์งˆ์ด๋‚˜ ์ง‘์•„์œผ๋กœ ๋Œ€์ฒด๋˜๋ฉด์„œ ๋ฆผํ”„์ ˆ์˜ ๊ฐ€์šด๋ฐ ๋ถ€๋ถ„์ด hyperechoic(white)ํ•˜๊ฒŒ ๋ณด์ž„.
โ‡’ ์žฅ๊ฐ„๋ง‰ ๋ฆผํ”„์ ˆ์— target lesions + ๊ทผ์œก์ธต >3mm โ‡’ SCL์œผ๋กœ ์ž ์ • ์ง„๋‹จ.
โœ… SCL vs. LPE - Immunophenotyping (๋ฉด์—ญํ‘œํ˜„ํ˜• ๊ฒ€์‚ฌ)
  • LL์€ B-cell lymphoma๊ฐ€ ํ”ํ•œ ๋ฐ˜๋ฉด, SCL์€ T-cell lymphoma๊ฐ€ ํ”ํ•˜๋‹ค.
  • small T cell์€ ํ˜•ํƒœํ•™์ ์œผ๋กœ ์ •์ƒ ๋ฆผํ”„๊ตฌ์™€ ๊ตฌ๋ถ„์ด ์–ด๋ ค์›€. โ‡’ H&E staining ์ฒ˜๋Ÿผ ์ผ๋ฐ˜์ ์ธ ์—ผ์ƒ‰์„ ํ–ˆ์„ ๋•Œ LPE(๋ฆผํ”„๊ตฌ์„ฑ ์žฅ์—ผ)์™€ ์ž˜ ๊ตฌ๋ถ„๋˜์ง€ ์•Š์Œ.
  • Immunophenotyping : ์ข…์–‘์ธ์ง€ ์—ผ์ฆ์ธ์ง€ ๊ตฌ๋ถ„ํ•˜๊ธฐ ์œ„ํ•ด ์ข…์–‘์—์„œ ๋ฐœํ˜„๋˜๋Š” ์ˆ˜์šฉ์ฒด ๋‹จ๋ฐฑ์งˆ์„ ๊ฒ€์‚ฌํ•จ.
    • ์—ผ์ฆ์€ ๋ฆผํ”„๊ตฌ๊ฐ€ ์ „๋ฐ˜์ ์œผ๋กœ ์ฆ๊ฐ€, ์ข…์–‘์€ ํ•œ์ข…๋ฅ˜๋งŒ ๊ธ‰์†๋„๋กœ ๊ณผ์ฆ์‹.
    • ์ด๋ฅผ ์ด์šฉํ•ด์„œ ํ•˜๋Š” ๊ฒ€์‚ฌ๊ฐ€ 3๊ฐ€์ง€ ์žˆ์Œ.

1 - Immunohistochemistry (๋ฉด์—ญ์กฐ์งํ™”ํ•™๊ฒ€์‚ฌ) (or Immunocytochemistry)

  • T cell์€ CD3 ๋ฐœํ˜„, B cell์€ CD79ฮฑ ๋ฐœํ˜„. โ†’ ๊ฐ๊ฐ์— ํŠน์ด์ ์ธ ํ•ญ์ฒด๋ฅผ ๋ถ™์—ฌ ์—ผ์ƒ‰.
    • ๋‘˜ ๋‹ค ์—ผ์ƒ‰๋˜๋ฉด โ‡’ ์—ผ์ฆ (IBD)
    • ํ•˜๋‚˜๋งŒ ์—ผ์ƒ‰๋˜๋ฉด โ‡’ ์ข…์–‘ (CD3๋งŒ = T cell lymphoma / CD79ฮฑ๋งŒ = B cell lymphoma)
  • ๋ฉด์—ญ ์—ผ์ƒ‰์€ ๋ณดํ†ต [๊ฐˆ์ƒ‰ = ์–‘์„ฑ]

2 - Flow cytometry (์œ ์„ธํฌ ๋ถ„์„)

  • ํ•ญ์ฒด๋ฅผ ๋ถ™์ด๋Š” ์›๋ฆฌ๋Š” ๋™์ด๋ž—์ง€๋งŒ, ์—ฌ๋Ÿฌ ํ•ญ์ฒด๋ฅผ ํ•œ๋ฒˆ์— ๋ถ™์ด๊ณ  ๋ ˆ์ด์ €๋กœ ์„ธํฌ์˜ ๋ถ„ํฌ๋ฅผ ํ™•์ธ
    โ†’ ์ž์„ธํ•จ, ๊ฐœ๋ณ„ ์„ธํฌ๋ฅผ ๋ณผ ์ˆ˜ ์žˆ์Œ, ํ•œ ๋ฒˆ์— ์—ฌ๋Ÿฌ ํ•ญ์ฒด.
  • T cell์— ๋ถ™๋Š” ํ•ญ์ฒด๋Š” CD3, CD4, CD5, CD8 ์ฒ˜๋Ÿผ ๋‹ค์–‘ํ•˜๊ฒŒ ๋ถ™์Œ. T cell์ด๋ฉด 3์€ ๋ฌด์กฐ๊ฑด ์žˆ์ง€๋งŒ, ๋‚˜๋จธ์ง€๋Š” ์ข…๋ฅ˜์— ๋”ฐ๋ผ ๋‹ค๋ฆ„ (helper T cell์€ 3&4 ์–‘์„ฑ, cytotoxic T cell์€ 3&8 ์–‘์„ฑ ๋“ฑ)
  • ์žฅ์ ) FNA๋งŒ์œผ๋กœ ํ•  ์ˆ˜ ์žˆ๊ณ , aberrant form๊นŒ์ง€ ๋ณผ ์ˆ˜ ์žˆ์Œ (4&8 ๋‹ค ๋ถ™์–ด์žˆ๊ฑฐ๋‚˜.. ์ข€ ์ด์ƒํ•œ ๊ฒฝ์šฐ)
  • ๋‹จ์ ) ์‚ด์•„์žˆ๋Š” ์„ธํฌ์—์„œ๋งŒ ๊ฒ€์‚ฌ ๊ฐ€๋Šฅ, ๊ฒ€์‚ฌ ๋ณด๋‚ด๊ธฐ ์–ด๋ ค์šธ ์ˆ˜๋„.

CD4 ์–‘์„ฑ์ด๋‚˜ CD8 ์–‘์„ฑ์€ ์—†๋Š”๋ฐ, Co-expression (CD4+CD8) ์ˆ˜์น˜๊ฐ€ ๋†’์Œ. ์ •์ƒ ์„ธํฌ๊ฐ€ ์•„๋‹ˆ๋ผ, ์˜ˆํ›„๊ฐ€ ์—„์ฒญ ์•ˆ ์ข‹์€ lymphoma.

3 - PARR ( PCR assay for Antigen Receptor Rearrangement)

  • B/T cell ํ‘œ๋ฉด์˜ ํ•ญ์› ํ™•์ธ์ด ๋ชฉ์ ์ด๋ฏ€๋กœ โ†’ ํ•ด๋‹น ํ•ญ์›์„ codingํ•˜๋Š” ๋‹จ๋ฐฑ์งˆ์„ codingํ•˜๋Š” DNA๋ฅผ ์ฆํญ์‹œ์ผœ์„œ ์ง„๋‹จ
  • Monoclonal peak โ†’ B cell or T cell๋งŒ ์ฆ์‹ โ‡’ Neoplasia
  • Polyclonal peak โ†’ ์—ฌ๋Ÿฌ ๊ฐœ๊ฐ€ ์ฆ์‹ โ‡’ Inflammation/immune-mediated/infection
  • ์žฅ์ ) ์ฃฝ์€ ์„ธํฌ์—๋„ ํ•  ์ˆ˜ ์žˆ์Œ
  • ๋‹จ์ ) abberant form๊นŒ์ง€ ๊ฒ€์‚ฌํ•  ์ˆœ ์—†์Œ.

  • PARR, Flow, ICC - ๋น„์šฉ ๋ฌธ์ œ ์•„๋‹ˆ๋ฉด ๋ณดํ†ต 3๊ฐœ ๋‹ค ํ•ด์„œ ์ƒํ˜ธ๋ณด์™„์  ๊ฐ๋ณ„
  • leukemia์ธ์ง€ lymphoma์ธ์ง€ ๊ฐ๋ณ„ ๊ฐ€๋Šฅ

Treatment

  • LL : Aggressive chemotherapy
    • ์™„์น˜๋Š” ์–ด๋ ต์ง€๋งŒ ์™„ํ™”์  ์น˜๋ฃŒ ๊ฐ€๋Šฅ.
    • ๋ฐ˜์‘ ์ข‹์œผ๋ฉด doxorubicin ๊ฐ™์€ ๊ฐ•ํ•œ ํ•ญ์•”์ œ๋กœ ํ•ญ์•” ์น˜๋ฃŒ ๊ฐ€๋Šฅ, ์™„์ „ ๊ด€ํ•ด(๋ณด์ด๋Š” ๊ฒƒ๋งŒ ์—†์• ๋Š”) ๋ชฉํ‘œ.
  • Feline SCL
    • PDS์™€ chlorambucil โ‡’ ์ด๊ฒƒ๋งŒ ๋จน์–ด๋„ ๋ฐ˜์‘์ด ์ข‹๋‹ค.

Prognosis

  • LL : ํ•ญ์•” ์น˜๋ฃŒ์— ์ž˜ ๋ฐ˜์‘ํ•  ์ˆ˜๋Š” ์žˆ์œผ๋‚˜, long-term prognosis๋Š” ๋งค์šฐ ๋‚˜์˜๋‹ค.
    • 24์ฃผ ํ•ญ์•” ํ”„๋กœํ† ์ฝœ, ๊ณ„์† ํ•ญ์•” ์น˜๋ฃŒ ํ•˜๋ฉด์„œ ๋ฒ„ํ‹ฐ๋Š” ๊ธฐ๊ฐ„์ด 12๊ฐœ์›”.
    • ์น˜๋ฃŒ ์•ˆ ํ•˜๋ฉด 1-3๊ฐœ์›”.
  • SCL : ์ง„๋‹จ์€ ์–ด๋ ต์ง€๋งŒ ๊ฒฝ๊ตฌ ํ•ญ์•”์ œ์— ๋ฐ˜์‘ ์ข‹์Œ, 2-3๋…„์€ ์ƒ์กด ๊ฐ€๋Šฅ.

3.11 Intestinal adenocarcinoma

Etiology

  • ๊ณ ์–‘์ด๋ณด๋‹ค ๊ฐœ์—์„œ ๋” ํ”ํ•œ ์ข…์–‘
  • intestinal obstruction ์œ ๋ฐœ : ๋ณดํ†ต diffuseํ•˜์ง€๋งŒ, focalํ•  ์ˆ˜๋„.
    • Diffuse intestinal thickeing
    • Focal circumferential mass

Clinical signs

Weight loss, vomiting

Diagnosis

  • Ultrasound-guided FNA : FNA๋กœ ์กฐ์ง์„ ์–ป๊ธฐ ์‰ฌ์šด ํŽธ
  • Endoscopy : ์กฐ์ง ๊ฒ€์‚ฌ ํ•„์š”์‹œ
  • Surgery
    • Scirrhous carcinomas(๊ฒฝํ™”์„ฑ ์•”์ข…) : ๋”ฑ๋”ฑํ•ด์„œ ๋–จ์–ด์ ธ ๋‚˜์˜ค์ง€ ์•Š์Œ, FNA๋กœ ์•ˆ ๋˜๊ณ  ์ˆ˜์ˆ ์  ์ ˆ์ œ ํ•„์š”.

Treatment & Prognosis

  • ์™ธ๊ณผ์ ์œผ๋กœ ์„ ์•”์ข… ์™„์ „ ์ ˆ์ œ (ํ•ญ์•”์ œ ๋ฐ˜์‘ ๋‚ฎ์€ ํŽธ)
  • ์ˆ˜์ˆ  ์น˜๋ฃŒ๊ฐ€ ๊ฐ€๋Šฅํ•˜๋ฉด ์˜ˆํ›„ good
  • ์ˆ ํ›„ ํ•ญ์•” ์น˜๋ฃŒ๋Š” ํฌ๊ฒŒ ํšจ๊ณผ๊ฐ€ ์—†์Œ

3.12 Intestinal leiomyoma, leiomyosarcoma, stromal tumor

Etiology

  • Connective tissue tumors (๊ฒฐํ•ฉ์กฐ์ง ์ข…์–‘) : Distinct mass, ๊ฒฝ๊ณ„๋ฅผ ๊ฐ€์ง€๊ณ  focalํ•˜๊ฒŒ ์ž๋žŒ.
    • ์กฐ๊ธฐ ๋ฐœ๊ฒฌ ์‹œ ์ˆ˜์ˆ ์  ์ ˆ์ œ๊ฐ€ ๊ฐ€๋Šฅํ•  ์ˆ˜๋„.
  • Small intestine & stomach์—์„œ ๋ฐœ์ƒ
  • Older dogs : ๋‚˜์ด๋“  ๊ฐœ์—์„œ ๋งŽ์ด ์ƒ๊น€.

Clinical signs

  • Intestinal hemorrhage (์žฅ์ถœํ˜ˆ)
  • Iron deficiency anemia (์ฒ  ๊ฒฐํ•์„ฑ ๋นˆํ˜ˆ)
  • Obstruction (ํ์ƒ‰)
  • Hypoglycemia : paraneoplastic effect๋กœ ๋ฐœ์ƒ (๐Ÿ”—LL์˜ paraneoplastic effect; PTH-rP)
    • ์ข…์–‘์—์„œ IGF-2(Insulin-like Growth Factor 2) ๋ถ„๋น„ โ†’ ์ธ์А๋ฆฐ๊ณผ ๋น„์Šทํ•ด์„œ, ํ˜ˆ๋‹น์ด ์ €ํ•˜๋จ.
    • ์ž˜ ๋จน๋Š”๋ฐ๋„ ํ˜ˆ๋‹น์ด ๋–จ์–ด์ง€๋ฉด ๊ฒฐํ•ฉ์กฐ์ง ์ข…์–‘ ์˜์‹ฌ.
    • Glucose ๋‚ฎ์€๋ฐ, insulin๋„ ๋‚ฎ์Œ.

Diagnosis

  • FNA
  • biopsy : sarcoma์˜ ๊ฒฝ์šฐ FNA๋กœ ์ƒ˜ํ”Œ ํ™•๋ณด๊ฐ€ ์–ด๋ ค์šธ ์ˆ˜๋„ ์žˆ์Œ.

Treatment &Prognosis

  • Surgical excision โ‡’ ์™„์ „ ์น˜๋ฃŒ ๊ฐ€๋Šฅ
  • Palliative chemotherapy : ์™„์น˜๋Š” ์•„๋‹ˆ์ง€๋งŒ ์™„ํ™”์  ์ฒ˜์น˜.
  • ์ „์ด๊ฐ€ ์žˆ์œผ๋ฉด ์˜ˆํ›„๊ฐ€ ๋‚˜์จ.

3.13 Acute colitis, proctitis (๊ธ‰์„ฑ ๊ฒฐ์žฅ์—ผ)

๋ณดํ†ต ๊ฒฐ์žฅ์—ผ๊ณผ ์ง์žฅ์—ผ ํ•จ๊ป˜ ๋‚˜ํƒ€๋‚จ.

Etiology

  • 3์ผ ์ •๋„๋Š” ์ง€์ผœ๋ด๋„ ๋จ. ์ด์œ  ์—†์ด ๋ฐœ์ƒํ•ด์„œ self-limiting
    • Bacteria, diet, parasites(rare), rough foreign object ๋“ฑ ์›์ธ์€ ๋‹ค์–‘.

Clinical features

  • ๊ฐœ์—์„œ ๋” ํ”ํ•จ (์•„๋ฌด๊ฑฐ๋‚˜ ์ฃผ์›Œ๋จน์–ด์„œ)
  • Good condition : ๋ณดํ†ต ์ปจ๋””์…˜์€ ์ข‹์Œ
  • Large bowel diarrhea โ†’ hematochezia(ํ˜ˆ๋ณ€), fecal mucus(์ ์•ก์ด ๋ฌป์Œ), tenesmus(์ด๊ธ‰ํ›„์ฆ)
  • Vomiting : ๋“œ๋ฌผ๊ฒŒ ๊ตฌํ†  ๊ฐ™์ด ํ•จ

Diagnosis

  • ์ง์žฅ ๊ฒ€์‚ฌ, ํ™•์‹คํ•œ ์›์ธ ๋ฐฐ์ œ(์‹์ด ๋ณ€ํ™”๋‚˜ ๊ธฐ์ƒ์ถฉ ๊ฐ์—ผ), ๋Œ€์ฆ ์น˜๋ฃŒ์— ๋ฐ˜์‘์„ฑ ์žˆ์œผ๋ฉด ์ž ์ • ์ง„๋‹จ
  • ํ™•์ง„์ด ํ•„์š”ํ•˜๋ฉด colonoscopy & biopsy โ†’ ์ด๋Ÿฐ ๊ฒฝ์šฐ๋Š” ๊ฑฐ์˜ ์—†์Œ.
  • ๋Œ€๋ถ€๋ถ„ ํ•ญ์ƒ์ œ ์ฒ˜์น˜๋กœ ์ข‹์•„์ง (=์ž ์ • ์ง„๋‹จ)

Treatment & Prognosis

  • ์ ˆ์‹(withholding food) โ†’ 3์ผ ์•ˆ์— ์ข‹์•„์ง
  • ๋Œ€์ฆ์น˜๋ฃŒ (symptomatic therapy), ํ•„์š” ์‹œ ์ˆ˜์•ก ์ฒ˜์น˜
  • ์ด๊ธ‰ํ›„์ฆ ์‹ฌํ•˜๋ฉด ํ•ญ๋ฌธ ๋ถ€์œ„ ์ฐฐ๊ณผ์ƒ์ด ์žˆ์„ ์ˆ˜ ์žˆ์Œ (rare) โ†’ ์†Œ๋…, ํ•ญ์ƒ ์—ฐ๊ณ 
  • ๊ด‘๋ฒ”์œ„ ํ•ญ์ƒ์ œ ์น˜๋ฃŒ
  • stool softener : ๋ณ€์„ ๋ถ€๋“œ๋Ÿฝ๊ฒŒ ํ•˜๋Š” ์•ฝ๋ฌผ (Lactulose ๋“ฑ)
  • ์˜ˆํ›„๋Š” ์•„์ฃผ ์ข‹๋‹ค.

3.14 Granulomatous, histocytic ulcerative colitis

์œก์•„์ข…์„ฑ ์กฐ์ง๊ตฌ ์นจ์œค ๊ฒฐ์žฅ์—ผ

Etiology

  • IBD๋Š” ํŠน๋ฐœ์„ฑ์œผ๋กœ ๋ถ€์ ์ ˆํ•œ ๋ฉด์—ญ ์ž‘์šฉ์— ์˜ํ•ด ๋ฐœ์ƒ
  • ๋ฐ˜๋ฉด ์ด ๊ฒฝ์šฐ ๋ช…ํ™•ํ•œ ์›์ธ : ์นจ์Šต์ ์ธ E. coli (adherent and invasive E. coli, AIEC) ์— ์˜ํ•ด ๋ฐœ์ƒ.
    • ํ•ญ์ƒ์ œ๋ฅผ ์“ฐ๋ฉด ๋ฐ˜์‘์ด ์ข‹์Œ(enrofloxacin-ํ€ด๋†€๋ก  ๊ณ„ํ†ต). ์Šคํ…Œ๋กœ์ด๋“œ ์“ฐ๋ฉด ์•ˆ ๋จ.
  • Boxers, Frech Bulldogs์—์„œ ์ฃผ๋กœ ๋ฐœ์ƒ.

Clinical features

  • ์ฒ˜์Œ์—๋Š” ์„ค์‚ฌ+ํ˜ˆ๋ณ€ & healthy
  • ์ง„ํ–‰์„ฑ(progressive) : weight loss, hypoalbuminemia
    • ๊ด‘๋ฒ”์œ„ํ•œ ์—ผ์ฆ์œผ๋กœ ์ ์  ์ ๋ง‰ ํˆฌ๊ณผ๋„๊ฐ€ ์ฆ๊ฐ€ํ•จ. โ†’ ์•Œ๋ถ€๋ฏผ ๊ฐ์†Œ, ์ฒด์ค‘ ๊ฐ์†Œ
  • ๊ธ‰์„ฑ ๊ฒฐ๋ง‰์—ผ์€ ๋ณดํ†ต 3์ผ ์ •๋„ ๋‘๋ฉด ๋‚ซ์ง€๋งŒ, ๋ฐ•์„œ๋‚˜ ๋ถˆ๋…์ธ ๊ฒฝ์šฐ ์ง„ํ–‰๋˜๋ฉด ์œ„ํ—˜ํ•ด์งˆ ์ˆ˜ ์žˆ์œผ๋ฏ€๋กœ ์ผ๋‹จ ํ•ญ์ƒ์ œ ์ฒ˜์น˜ + ๋น ๋ฅธ ์ง„๋‹จ์ด ์ค‘์š”.

Diagnosis

  • EARLY endoscopy๋กœ ์กฐ์ง ๊ฒ€์‚ฌ โ†’ E. coli ์ง„๋‹จ
  • Histopathology : ์„ธ๊ท ์„ ํƒ์‹ํ•˜๋Š” macrophage ํ™•์ธ
    • PAS ์—ผ์ƒ‰ ์–‘์„ฑ (PAS : ๋Œ€์‹์„ธํฌ ์•ˆ์— ์„ธ๊ท ์ด ์žˆ์„ ๋•Œ ์–‘์„ฑ)

Treatment

  • Antibiotic responsive : Enrofloxacin
  • ํ•ญ์ƒ์ œ๋Š” ๋ฐ˜๋“œ์‹œ 8์ฃผ ์ด์ƒ ๋จน์—ฌ์•ผ.
    • ๋ณดํ†ต 2์ฃผ ์•ˆ์— ์ข‹์•„์ ธ์„œ, ๋ณดํ˜ธ์ž๊ฐ€ ์ž„์˜๋กœ ์ค‘๋‹จํ•  ์ˆ˜ ์žˆ์Œ โ†’ ํ•ญ์ƒ์ œ ๋‚ด์„ฑ, ์นจ์Šต์  E. Coli๊ฐ€ ๋” ํ™œ๋™. (C/E ์ค‘์š”!!)

Prognosis

  • ์ €ํ˜ˆ๋‹น ์•„๋‹ˆ๊ณ  (before it is cachexia), ์•ฝ 8์ฃผ ์ž˜ ๋จน์œผ๋ฉด (long enough antibiotics)
  • ์˜ˆํ›„๋Š” ์ข‹๋‹ค!

3.15 Anal sac (apocrine gland) adenocarcinoma

Etiology

  • ํ•ญ๋ฌธ๋‚ญ์˜ apocrine gland์— ์ƒ๊ธฐ๋Š” ์ข…์–‘ (DDx. ํ•ญ๋ฌธ๋‚ญ์—ผ)
  • ์ž„์ƒ์—์„œ AGASACA ๋ผ๊ณ  ๋ถ€๋ฆ„. (Apocrine Gland / Anal Sac / AdenoCArcinoma)
  • older female dogs
  • โ‡’ ํ•ญ๋ฌธ๋‚ญ ์ข…์–‘์ธ๋ฐ ๋‚˜์ด๊ฐ€ ๋งŽ์Œ + ํ˜ˆ๊ฒ€์ƒ ์นผ์Š˜ ๋†’์Œ โ†’ AGASACA ๋ฐ˜๋“œ์‹œ ์˜์‹ฌ.

Clinical Features

  • ๋งŒ์ง€๋ฉด mass ์ด‰์ง„๋จ.
  • Paraneoplastic syndrome : PTH-rP ๋ถ„๋น„ โ†’ Ca ๋†’์•„์ง (PTH-rp ๋ถ„๋น„ํ•˜๋Š” ์ข…์–‘ : LL(T cell lymphoma), AGASACA)
    • ์ฆ๊ฐ€ํ•œ ์นผ์Š˜์ด ์†Œํ™”๊ธฐ์— ์นจ์ฐฉ โ†’ ์†Œํ™”๊ธฐ ์šด๋™์„ฑ ๋–จ์–ด์ง โ†’ ๊ตฌํ† , ๋ณ€๋น„
    • ์ฆ๊ฐ€ํ•œ ์นผ์Š˜์ด ์‚ฌ๊ตฌ์ฒด์— ์นจ์ฐฉ โ†’ ์˜ค์คŒ ๋†์ถ• ๋Šฅ๋ ฅ ๊ฐ์†Œ + ์ง‘ํ•ฉ๊ด€์—์„œ ADH ๋ฐ˜์‘์„ฑ ๊ฐ์†Œ โ†’ ๋‹ค๋‡จ - ๋‹ค์Œ
    • ์ฒด์ค‘ ๊ฐ์†Œ
  • metastatic sublumbar lymphadenopathy(์š”์ถ”ํ•˜๋ฆผํ”„์ ˆ) โ†’ ์ดˆ๊ธฐ๋ถ€ํ„ฐ ์ž˜ ์ „์ด๋จ, ์ฒ™์ถ” ์•„๋ž˜ ์ด‰์ง„ํ•ด์„œ ํ™•์ธ

Diagnosis

  • Cytologic, Histopathology
    • ์ƒํ”ผ์„ธํฌ์˜ clumping, vaculolization โ†’ Gland ์œ ๋ž˜ ์ƒํ”ผ์„ธํฌ ์•…์„ฑ ์ข…์–‘
    • ๊ทธ ์™ธ nucleoli(ํ•ต์†Œ์ฒด) ๋šœ๋ ท, anysocytosis
  • Blood work : Hypercalcemia
  • ์ดˆ์ŒํŒŒ๋กœ๋Š” ๋ณด๊ธฐ ์–ด๋ ค์›€ โ†’ sublumbar lymphadenopathy ์—ฌ๋ถ€๋ฅผ ์ง์žฅ๊ฒ€์‚ฌ๋กœ ์ด‰์ง„ํ•˜๋Š” ๊ฒŒ ๋‚˜์Œ

Treatment & Prognosis

  • ์ตœ๋Œ€ํ•œ ๋นจ๋ฆฌ ์ ˆ์ œํ•œ ํ›„ ํ•ญ์•”์น˜๋ฃŒ๋ฅผ ๋ณ‘ํ–‰ !!
    • Surgical resection
    • Palliative chemotherapy : Adjuvant therapy๋กœ ์ˆ˜์ˆ  ํ›„ ์™„ํ™” ์น˜๋ฃŒ๋„ ๊ฐ€๋Šฅ
  • ์˜ˆํ›„๋Š” guarded (์•„์ฃผ ๋‚˜์˜์ง„ ์•Š์€๋ฐ ๊ณ„์† ์ง€์ผœ๋ด์•ผ ํ•จ.)